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INTRODUCTION 
 Siddha system of medicine is a potent and unique indigenous system of medicine, which 
deals with the disease of human efficiently with the knowledge of both subtle and also the gross 
material body. Siddhi means knowledge or wisdom. The ultimate aim of siddha is to attained 
perfection or heavenly bliss. 
 
 
 
 
 
 
 
 
 
 
 
 
     As per Siddha system the human body is made up of three vital humors. Which are called as 
Vaatham, Pitham and Kabam respectively. In normal state the equilibrium of these three vital 
humor are the body as well as mind very healthy and stable. Vitiations of between these humors 
are the cause diseases in our body as well as mind.  
    
       Siddha system of medicine has mentioned a lot about Mana noigal like Madha azivu, 
Madha noi, Kirigai, Unmadham[1]. Siddhars also mentioned about the treatment aspects for 
Mana noigal. The symptoms of mana noigal include hallucinations, lack of interest in all 
activities, fatigue, depressed mood, insomnia, anxiety etc...In this condition the symptoms are 
comparably correlated with the Disorder  Viyagula Unmaatham which is one of the six types of 
Unmaatham. In this disorder it includes the symptoms such as depressed mood, lack of 
concentration, crying or worrying without any reason, fear in contact with other persons, 
insomnia as per the literatures in Siddha. 
        Now a days in the hurry world almost every human being got the stress regularly and 
repeatedly. Unfortunately there is no time or no pathways to relieve the stress in a routine 
lifecycle leads to restlessness, Irritability, Lower tolerance level, Uncompromised behavior, 
Unable to accept and adjust certain situations, Ignore to share the love between their family 
members and friends. These are all conditions make the life very unsatisfactory and unhappier. 
So,It will probably reflects on the mental health. 
        Due to stress the relationship between various people such as Husband and wife,Parents 
and Children, Teacher and student, Doctor and Patient , Office manager and staffs  are now 
haven`t any proper understanding, respect, obedience, genuineness and holistic nature. Even the 
 
 
school students are also getting much stress from their school life and various additional 
coaching classes without adequate rest and mental refreshment. It is a alarming sign for us. 
        Hence, the repeated and prolonged stress is one of the major factor for getting depression. 
That the people can`t tolerate a simple failures in their life and can`t perform well against a 
crucial situations. It may spoil our society`s health and probably our nation`s wealth also. 
      So,I have the aim to treat and prevent depression with our native system of medicine with 
the scientific validation. I took the topic viyakula unmaatham significantly relavant to the 
Depression in modern diagnosis. 
      I have choosen the Internal medicine Venpoosani kirutham and External medicine Seeraga 
thylam with few scientific and siddha logical aspects.The venpoosani kirutham`s ingredients 
have some chemical constituents which are effective on the psychological issues very 
well.Kirutham (Nei) is one of the type of  internal medicine which belongs the base as 
ghee.So,the medicine can cross the Blood Brain Barrier and acts on the brain appreciably. As 
per siddha literatures  the seeraga thylam is very effective to normalize the elevated pitham 
which is the humor mostly responsible for mental illnesses. 
        Now a days, considerably more number of patients reporting daily for the treatment for 
Viyagula Unmaatham in Ayothidoss pandithar Hospital,National Institute of Siddha.Hence the 
author has choosen this disease with the trial drug “Venpoosani kirutham”(Internal) “Seeraga 
Ennai”(External). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM AND OBJECTIVES 
 
 
AIM: 
 
 
         To Evaluate the efficacy  of  VENPOOSANI KIRUTHAM (internal) and SEERAGA 
THAILAM  (external) in the treatment of Viyakula Unmatham. 
 
OBJECTIVE: 
➢  To make a detailed clinical evaluation of the disease by careful examination of 
 
etiology, symptoms, complication, treatment and Prognosis 
 
➢  To study the Siddha and Modern aspects of Viyakula unmatham (Depression) 
➢  To study the Siddha basic principles towards the efficacy of trial medicines. 
➢  To carry out the Biochemical analysis of trial medicine of VENPOOSANI 
KIRUTHAM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITRATURE 
 
 SIDDHA ASPECT 
 
 
 
Introduction 
 
In Siddha system, all psychiatric diseases are come under the kirigai noigal. Kirigai 
maruthuvam, the psychiatry in Siddha system of medicine is propounded by several Siddhars 
of whom the most renowned are AGATHIYAR, YUGIMUNIVAR and THERAIYAR. In Siddha 
system, the physiology of human body is dealt in 96 thatthuvangal (philosophy). Of the 96 
thatthuvam, Manam (mind), Buththi (wisdom, decision making), Chitham(determination), 
Agangaram (accomplishment) are the responsible for the mental well-being. Agangaram is 
the innate character of manam. Manam(mind) is responsible for thinking, reasoning, planning 
and self-realization. 
 
The mind and physique are inseparable and inter dependable. Manam is both receptive 
and executive. In-appropriate food, seasonal variations, somatic diseases, and drug abuse are 
some of the factors that influence the mind. This stimulates the three humors vali, azhal and 
iyam, especially deranges vali or azhal or often the predominance of azhal humor over the 
other two, thereby manifest mana noigal (mental disorders). Agathiyar maanidar kirigai nool 
and yugi Sinthamani-800 are noteworthy psychiatric literature in Siddha system. They 
classified the clinical variety of mental illness, based on symptomatology. It is more probably 
correlates with modern psychiatric illnesses like depression, schizophrenia, mania, convulsive 
disorders, neurotic illness, drug dependence and toxic psychosis etc. 
 
 
UNMATHAM (DEFECTED NORMAL MENTAL STATE): 
 
 
Synonyms: veri noi, pithu noi, paithiya noi ,pitha noi, unmatham. 
 
Definiton- 
 
 
It is a psychic disorder, develops as changed normal mental state due to the vitiation of three 
humors viz vatham, pitham and kapham. Changed mental state, loss of intelligence, articulation 
defect, dancing, singing, continuous working mania, quarrelling and beating. 
Noi varum vazhi[2]: 
 
 
The disease occurs due to destruction physical and mental factors of the body. The 
reasons for this are, 
➢  Increased intake of food, 
➢  Excessive starvation, 
➢  Drug abuse, 
➢  Increased desires, 
➢  Frighten, 
➢  Frequent agitation. 
 
Hence the disease can occur in association with vadha disease like pakkavatham, valipu 
noi, its also seen in persons those who were undergoing ailments for long time and also in 
postpartum ladies whose health is severely affected. 
 
The disease can also occur due to wrong practice of yogam during the thuriya avaththai 
state. Since this disease occurs due to deranged azhal kutram(piththam),which  is also called 
as paithiya noi. The persons whose mental state is disturbed and who keeps on blabbering 
whatever he likes they are commonly called as paithiyam. 
AETIOLOGY: 
 
In the text book of yugi maa munivar vaiththiya sinthamani 800, 
 
“ÁÕ×§Á ÒÄ¢ôÒ¨Èô ÒÅ÷ôÒ Á¢ïºø 
ÁÉ¾¢§Ä Ðì¸í¸ Ç¨¼¾Ä¡Öõ 
¦¿Õ×§Á ¦¿ÕôÒ¦ÅÂ¢ø §¸¡Àó ¾ýÉ¢ø 
¿¢ò¾¢¨Ã¾¡ ¿¢øÄ¡Áø Å¢Æ¢ò¾¢Õò¾ø 
«Õ×§Á Âì¸¢É¢Â¢ü ¦À¡º¢ì¸¡ Ðñ¼ 
Ä¾¢¸Á¡öô ¦Àñ§À¡¸ ÁÛÀ Å¢ò¾ø 
¿Õ×§Á ¿¡À¢ìÌ §Á§Ä ¿¢ýÚ 
 
 
½¡Ê§Â ¸ñ¼Áð¼¡ Â¢ÕìÌõ À¡§Ã” 
Vihara Pitham 
“¦º¡øÄ§Å ÐÂ¢¦Ä¡Æ¢óÐ ¸ºóÐ Å¡¨Âò 
 ÐôÒÃÅ¡öô ÀÄ§ÀîÍõ Å¢ÕõÀ¢ ¼¡Ð 
¸øÄ§Å ¸ñ º¢ÅóÐ Óñ¼¡í  
ÁøÄ§Å Å¡ó¾¢¦Â¡Î ÁÂì¸ Á¡Ì 
 ÁÉÁÕ¸ Ä¡¸¢§Â Å¡ö¿£ åÚõ 
ÀøÄ§Å ÀðÉ¢¾¡ý Á¢¸ Å¢ÕìÌõ 
 À¡ÃÁ¡õ Å¢¸¡ÃÀ¢ò¾ô ÀñÀ ¾¡§Á”[3] 
 
➢ Sleeplessness, 
➢  Bitter taste in mouth, 
➢  Hatred , 
➢  Redness of eyes, 
➢  Pallor of body with body pain, 
➢  Vomiting, 
➢  Giddiness, 
➢  Lack of vigilance, 
➢  Dribbling of saliva. 
 
 
Unmaatha pitham 
 
 
“Å¢ÅÃÁ¡ö §ÁÉ¢¦ÂÄ¡ Á¢ÎìÌñ ¼¡Ì 
 Á¢ì¸¡É ¾£ÀÉó¾¡ý ¦Áò¾ Å¡Ìó 
¾ÀÃÁ¡öò ¾¨Ä¾¡Ûí ¸ÉòÐì ¸¡Ïó 
 ¾¡¢ìÌ§Á¡ ¡¢¼ó¾ýÉ¢ø Á¢¸ Å¢ÕìÌõ 
¯ÀÃÁ¡ ¦Â¡ÕÅÕ¼ý §Àº¢ ¼¡Á 
 ¾¢ÀÃÁ¡ö Å¡ö¿£÷¾¡ý ÅÊòÐ ¿¢üìï 
 
 
º¢ò¾ÁÐ ¸ÄíÌÓý Á¡¾ Á¡§Á”[4] 
 
 
➢  Increased anger, 
➢  Quarrelling, 
➢  Flatulence, 
➢  Lack of intelligence, 
➢  Redness of eyes, 
➢  Sleeplessness, 
➢  Weight gaining. 
 
 
 TYPES OF UNMATHAM[5]: 
 
 
           Unmatham has classified into 6 types, 
 
 
•   Vatha Unmatham: 
 
                          Affected mental state, articulation defect, dancing, singing, quarrelling and  
beating are the general symptoms of vatha unmatham. 
 
     •   Pitha unmatham: 
 
Frightening others, abnormal body movements, interested in cold items. 
 
•   Kapha unmatham: 
 
Insomnia, frightening others, sexual indulgence,self-centeredness, 
possessiveness. 
•   Mukkuttra unmatham: 
 
The mixed signs and symptoms of vatham, pitham and kapham unmatham is 
called mukkuttra unmatham. 
 
•   Viyagula unmatham: 
 
Anxiety and depression due to bereavement, sorrow and grief, paleness, loss of 
wealth and weeping are the symptoms of this disease. 
•   Nanju unmatham: 
 
Toxicity of metals and others, which affects the brain, drug abuse, tiredness of 
extremities, sensory organs, blackish discoloration of the body, general debility, 
weakness of the body and perplexity are the symptoms of these diseases. 
 
Murkurigal (EARLY SYMPTOMS) :- 
 
➢  Reduced mental function 
➢  Excessive anger. 
➢  Mood swings. 
➢  Low pitched or high-pitched voice. 
➢  Lethargy. 
➢  Blabbering and whispering always. 
➢  Abnormal behaviour. 
 
COMMON SYMPTOMS: 
 
 
 
 
 
 
 
 
 
 
➢  Mental instability, 
➢  Restlessness, 
➢  Loss of control, 
➢  Confined thoughts, 
➢  Speaking loudly, 
➢  Sleeplessness, 
➢  Blabbering, 
➢  Slurred speech, 
➢  Lack of interest, 
➢  Loss of strength. 
 
 
TREATMENT: 
 
 
 
 
 
 
 
 
Thiruvalluvar says in “Thirukkural” about physician‟s duty to study the disease, Study 
 
the cause, seek subsiding ways and do what is proper and effective. 
 
 
 
 
 
 
 
 
 
In Siddha system of medicine, the main aim of the treatment is to cure Udalpini and 
Manapini. Treatment is not only for treating disease but also for prevention and rejuvenation. 
In siddha system of medicine line of treatment are as follows, 
➢  Neekam (Treatment) 
➢  Niraivu (Rejuvenation) 
➢  Kappu (Prevention) 
 
1.Neekam (Treatment): 
 
 
•    
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     •    
 
•    
 
 
➢  Viresanam: 
 
Siddha system of medicine is based on three humors and hence the treatment is 
mainly aimed to bring the three humors to equilibrium state and thereby restoring the 
physiological condition of the seven thathus. 
➢  Internal medicine: 
 
The medicines which are taken internally are called as internal medicines. These are 
classified into 32 types, e.g. surasam, saaru, pittu, vadagam and chooranam, thylam 
 
➢  External medicine: 
 
The medicines which are applied externally are called as external medicines. These 
also classified into 32 types, e.g.kattu, patru, otradam, vedhu and thokkanam. 
 
➢  Anubanam(vehicle): 
 
 
 
 
 
 
 
 
 
 
➢  Pathiyam (Dietary Regimen): 
 
In mild conditions of the disease, salt and tamarind can be taken in little quantities. 
When the condition is severe, tamarind should be avoided and salt must be consumed after 
frying. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Substances used for neutralizing the three humors are: 
 
 
 
 
 
 
 
 
 
 
 
The patients are well motivated. The nature and course of the disease is explained to 
them, Life-style modification advised. 
 
3.Kappu (Prevention): 
 
Ideal measures mentioned in the Siddha classical text Pathartha guna chinthamani for 
healthy living as below, 
“¾¢ñ½Á¢ÃñÎû§Ç º¢ì¸ Å¼ì¸¡Áü 
 ¦Àñ½¢ýÀ¡ ¦Ä¡ý¨Èô ¦ÀÕì¸¡Áø - ¯ñÏí¸¡ø 
¿£÷ÍÕì¸¢ §Á¡÷¦ÀÕì¸¢ ¦¿öÔÕì¸¢ ÔñÀÅ÷ ¾õ 
 §ÀÕ¨Ãì¸¢ü §À¡§Á À¢½¢”[6] 
 
“¬Ú¾¢í¸ð ¦¸¡Õ¾¼¨Å ÅÁÉÁÕó ¾Â¢ø§Å¡õ 
 «¼÷¿¡ýÌ Á¾¢ì¦¸¡Õ¸¡ü §À¾¢Ô¨È Ñ¸÷§Å¡õ 
§¾ÚÁ¾¢ ¦Â¡ýÈ¨Ãì§¸¡÷ ¾Ã¿º¢Âõ ¦ÀÕ§Å¡õ 
 ¾¢í¸Ç¨Ãì ¸¢ÃñÎ¾Ãï ºÅÃÅ¢Õô ÒÚ§Å¡õ 
Å£ÚºÐ÷ ¿¡ð¦¸¡Õ¸¡ø ¦¿öÓØì¨¸ò ¾Å¢§Ã¡õ 
 Å¢Æ¢¸Ùì¸ï ºÉãýÚ  ¿¡ð¦¸¡Õ¸¡Ä¢Î§Å¡õ 
¿¡Ú¸ó¾õ ÒðÀÁ¢¨Å ¿Î¿¢º¢Â¢ý Ó¸§Ã¡õ 
 
 
 ¿ÁÉ¡÷ì¸¢í §¸Ð¸¨Å ¿¡Á¢ÕìÌ Á¢¼ò§¾”[7] 
 
The disease occurs due to activities that increase azhal and consuming food that increases 
azhal, so in order to correct the diseases we have to normalize the deranged azhal and there by 
the other factors. 
➢  Ghee based medicine, milk to be administered initially and take purgation and 
therapeutic vomiting may be advised. 
➢  Medicine which improves the strength of the body. 
➢  Yogam is the important kayakalpam to treat psychiatric diseases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MODERN ASPECT 
 
 
 
 
 
INTRODUCTION 
 
Depression is a common mental disorder that presents with depressed mood, loss of 
interest or pleasure, feelings of guilt or low self-esteem, disturbed sleep or appetite, low energy, 
and poor concentration. When these problems last for a short period of time, it may be called a 
passing case of “the blues.”  But it’s likely to be a depressive disorder when they last for more 
than two weeks and interfere with regular daily activities. 
 
Depressive disorders, also known as mood disorders, include three main types: major 
depression, persistent depressive disorder, and bipolar disorder. Depressive disorders can affect 
people of any age, including children, teenagers, adults, and older adults. 
 
 
 
 
 
 
CAUSES 
 
Depression varies person to person and occurs due to one or more reasons. Depression 
is most likely due to a combination of genetic, biological, environmental, and psychological 
factors. Occasionally it may appear for no obvious reason. 
 
 
Life events 
 
In many cases, the first time someone becomes depressed, it has been triggered by an 
unwelcome or traumatic event, such as being sacked, divorced, or physically or sexually 
assaulted. 
 
 
 
 
 
 
 
 
Loss 
Often events or experiences that triggers depression mainly associated with loss of 
something precious in life. It could be following the actual death of someone close, a major life 
change (such as moving house or changing jobs), or simply moving from one phase of life into 
another, e.g. as you reach retirement, children leave home, or you come to realize that you may 
never have a family of your own. 
 
It’s not just the negative experience that causes the depression, but how we deal with 
it. If the feelings provoked are not expressed or explored at the time, they fester and contribute 
towards depression. 
 
Anger 
 
In some cases, some people call depression ‘frozen anger’. You may have experienced 
something which left you feeling angry and helpless, and if you were unable to express your 
feelings at the time – perhaps because you were a child, or your feelings were unacceptable to 
others – the anger becomes internalized and is expressed as depression. 
 
Childhood experiences 
 
Traumatic event in childhood, or were abused physically or emotionally, or were not 
helped to learn good coping skills as you grew up, this can leave you less able to cope with 
difficulties as an adult. 
 
Women who have been the victim of physical, emotional, or sexual abuse, either as a 
child or perpetrated by a romantic partner are vulnerable to developing a depressive disorder 
as well. 
 
Physical conditions 
 
 
All medical illnesses and their treatment can act as nonspecific stressors, which may lead 
to mood disorders in predisposed individuals. However, sometimes certain medical conditions 
are believed to play a more direct role in causing the mood disorder (e.g. brain disease, certain 
infections, including HIV, and endocrine disorders). 
 
The following conditions may cause depression, but are sometimes overlooked because of 
the focus on their physical symptoms: 
 
 
 
•   Conditions affecting the brain and nervous system 
 
• Hormonal problems, especially thyroid and parathyroid problems; symptoms relating to 
the menstrual cycle or the menopause 
•   Low blood sugar 
 
•   Sleep problems. 
 
Different neuropsychiatric illnesses seem to be associated with an overabundance or a 
lack of some of these neurochemicals in certain parts of the brain. For example, a lack of 
dopamine at the base of the brain causes Parkinson's disease. Alzheimer's dementia seems to 
be related to lower acetylcholine levels in the brain. The addictive disorders are under the 
influence of the neurochemical dopamine. That is to say, drugs and alcohol work by releasing 
dopamine in the brain. The dopamine causes euphoria, which is a pleasant sensation. 
Individuals with anxiety, attention deficit hyperactivity disorder (ADHD), substance abuse, 
and developmental disabilities may be more vulnerable to developing depression. 
 
Side effects of medication 
 
Certain medications used for a variety of medical conditions are more likely than others 
to cause depression as a side effect, for example, many people become depressed after a heart 
attack, and this may be more likely if they are taking beta blocker medicines as part of their 
treatment. Specifically, some medications that are used to treat high blood pressure, cancer, 
seizures, extreme pain, and to achieve contraception can result in depression. Even some 
psychiatric medications like some sleep aids and medications to treat alcoholism and anxiety 
can contribute to the development of depression. 
Diet 
 
Poor diet and general lack of fitness can both contribute to depression. 
 
In addition, anecdotal evidence suggests that occasionally people become very 
depressed in response to some specific foods. Such a reaction is very individual, and people 
are often not aware of the particular food substance or drink that is causing the problem. But if 
you suddenly feel depressed for no apparent reason, it may be worth considering whether you 
have eaten or drunk something new, and whether this might have caused your sudden change 
of mood. If this is the cause, your mood should lift very quickly, so long as you don’t consume 
any more of the particular item. 
 
 
 
 
Street drugs and alcohol 
 
Alcohol is a depressant and will tend to make you feel worse overall. Some street drugs 
can also depress, especially if used repeatedly. Repeated use of drugs or alcohol, however, 
desensitizes the dopamine system, which means that the system gets used to the drugs and 
alcohol. Therefore, a person needs more drugs or alcohol to achieve the same high feeling. 
Thus, the addicted person takes more substance but feels less and less high and increasingly 
depressed. 
 
Genetics 
 
Although no specific genes for depression, have been identified, it does seem to run in 
families to some extent, and some of us are more prone to depression than others. This could 
also be because we learn behavior and ways of responding from our ancestors, as well as 
inheriting our genes from them. 
 
The effect of maternal-fetal stress on depression is currently an exciting area of 
research. It seems that maternal stress during pregnancy can increase the chance that the child 
will be prone to depression as an adult, particularly if there is a genetic vulnerability. It is 
thought that the mother's circulating stress hormones can influence the development of the 
fetus' brain  during pregnancy.  This  altered  fetal  brain  development  occurs in  ways  that 
predispose the child to the risk of depression as an adult. 
 
Major depression also seems to occur in generation after generation in some families, 
although not as strongly as in bipolar I or II. Indeed, major depression can also occur in people 
who have no family history of depression. 
 
Chemical changes in the brain: 
 
 
 
 
(Medial prefrontal affected in depressive mood, which is to planning cognitive 
behaviour, personality expression, decision making and moderating social behaviour) 
 
 
Brain imaging technologies, such as magnetic resonance imaging (MRI), have shown 
that the parts of the brain involved in mood, thinking, sleep, appetite, and behavior of people 
who have depression function differently than those of people without it. 
 
Because antidepressants work by changing brain chemistry, many people have assumed 
that depression must be caused by changes in brain chemistry that are then ‘corrected’ by the 
drugs. Some psychiatrists may explain you that you have a ‘chemical imbalance’ and need 
medication to correct it. But the evidence for this, apart from the effects of medication, is very 
weak, and if changes to brain chemistry occur, we don’t know whether these are the result of 
the depression or its cause. Although there are physical tests which are occasionally used in 
research on depression, they are not very accurate or consistent, and there are none that are 
done routinely to help make a diagnosis. 
 
Monoamine pathways, particularly those involving noradrenaline and 5- 
hydroxytryptamine (5- HT), innervate cortical and subcortical brain regions thought to be 
involved  in  mood  regulation.  Hypothesis  suggests  that  depressive disorder is  due to  an 
abnormality in a monoamine neurotransmitter system at one or more sites in the brain. Three 
monoamine transmitters have been implicated— serotonin (5- HT), noradrenaline, and 
dopamine. The latter two neurotransmitters are called catecholamines. Biochemical 
investigations in depressed patients have focused on the monoamine neurotransmitters because 
monoamine pathways appear to play an important role in the actions of effective antidepressant 
drugs. 
 
 
 
 
 
Finally, the depressive disorders appear to be associated with altered brain serotonin 
and norepinephrine systems. Both of these neurochemicals may be lower in depressed people. 
Please note that depression is "associated with" instead of "caused by" abnormalities of these 
neurochemicals because we really don't know whether low levels of neurochemicals in the 
brain cause depression or whether depression causes low levels of neurochemicals in the brain. 
 
 
DEPRESSION SYMPTOMS: 
 
Depression symptoms include: 
 
 
•   Feelings of sadness or unhappiness 
 
•   Irritability or frustration, even over small matters 
 
•   Loss of interest or pleasure in normal activities 
 
•   Reduced sex drive 
 
•   Insomnia or excessive sleeping 
 
•   Changes in appetite — depression often causes decreased appetite and weight loss 
 
•   In some people it causes increased cravings for food and weight gain 
 
• Agitation or restlessness — for example, pacing, hand-wringing or an inability to sit 
still 
•   Irritability or angry outbursts 
 
•   Slow thinking, speaking or body movements 
 
•   Indecisiveness, distractibility and decreased concentration 
 
• Fatigue, tiredness and loss of energy — even small tasks may seem to require a lot of 
effort 
• Feelings of worthlessness or guilt, fixating on past failures or blaming yourself when 
things aren't going right 
•   Trouble thinking, concentrating, making decisions and remembering things 
 
•   Frequent thoughts of death, dying or suicide 
 
•   Crying spells for no apparent reason 
 
•   Unexplained physical problems, such as back pain or headaches 
 
 
 
 
 
 
 
 
 
 
 
Depression symptoms in children and adolescent: 
 
Common symptoms of depression can be a little different in children and teens than 
they are in adults. 
• In younger children, symptoms of depression may include sadness, irritability, 
hopelessness and worry. 
• Symptoms in adolescents may include anxiety, anger and avoidance of social 
interaction. 
• Changes in thinking and sleep are common signs of depression in adolescents and 
adults but are not as common in younger children. 
• In children and teens, depression often occurs along with behavior problems and other 
mental health conditions, such as anxiety or attention-deficit/hyperactivity disorder 
(ADHD). 
•   Schoolwork may suffer in children who are depressed. 
 
Depression symptoms in older adults: 
 
 
Depression is not a normal part of growing older, and most seniors feel satisfied with 
their lives. However, depression can and does occur in older adults. Unfortunately, it often goes 
undiagnosed and untreated. Many adults with depression feel reluctant to seek help when 
they're feeling down. 
 
• In older adults, depression may go undiagnosed because symptoms — for example, 
fatigue, loss of appetite, sleep problems or loss of interest in sex — may seem to be 
caused by other illnesses. 
• Older  adults  with  depression  may  have  less  obvious  symptoms.  They  may  feel 
dissatisfied with life in general, bored, helpless or worthless. They may always want to 
stay at home, rather than going out to socialize or doing new things. 
• Suicidal thinking or feelings in older adults is a sign of serious depression that should 
never be taken lightly, especially in men. Of all people with depression, older adult men 
are at the highest risk of suicide. 
 
 
SIGNS AND SYMPTOMS OF DEPRESSIVE DISORDER: 
 
 
 
 
1. A depressive disorder is a syndrome (group of symptoms) that reflects a sad and/or 
irritable mood exceeding normal sadness or grief. More specifically, the sadness of depression 
is  characterized  by a  greater  intensity and  duration  and  by more  severe  symptoms  and 
functional disabilities than is normal. 
 
2. Depressive signs and symptoms are characterized not only by negative thoughts, 
moods, and behaviors but also by specific changes in bodily functions (for example, crying 
spells, body aches, low energy or libido, as well as problems with eating, weight, or sleeping). 
The functional changes of clinical depression are often called neurovegetative signs. This 
means that the nervous system changes in the brain cause many physical symptoms that result 
in diminished participation and a decreased or increased activity level. 
 
3. Certain people with depressive disorder, especially bipolar depression (manic 
depression), seem to have an inherited vulnerability to this condition. 
 
4. Depressive disorders are a huge public-health problem, due to its affecting millions 
of people. About 10% of adults, up to 8% of teens and 2% of preteen children experience some 
kind of depressive disorder. 
 
The statistics on the costs due to depression in the United States include huge amounts of direct 
costs, which are for treatment, and indirect costs, such as lost productivity and absenteeism 
from work or school. 
 
• Adolescents who suffer from depression are at risk for developing and maintaining 
obesity. 
 
 
 
• In a major medical study, depression caused significant problems in the functioning of 
those affected more often than did arthritis, hypertension, chronic lung disease, and 
diabetes, and in some ways as often as coronary artery disease. 
• Depression can increase the risks for developing coronary artery disease, HIV, asthma, 
and many other medical illnesses. Other complications of depression include its 
tendency to increase the morbidity (illness/negative health effects) and mortality 
(death) from these and many other medical conditions. 
• Depression can coexist with virtually every other mental health illness, aggravating the 
status of those who suffer the combination of both depression and the other mental 
illness. 
• Depression in the elderly tends to be chronic, has a low rate of recovery, and is often 
undertreated. This is of particular concern given that elderly men, particularly elderly 
white men have the highest suicide rate. 
 
5. Depression is usually first identified in a primary-care setting, not in a mental-health 
practitioner's office. Moreover, it often assumes various disguises, which causes depression to 
be frequently not diagnosed. 
 
6. In spite of clear research evidence and clinical guidelines regarding therapy, 
depression is often undertreated. Hopefully, this situation can change for the better. 
 
7. For full recovery from a mood disorder, regardless of whether there is a precipitating 
factor or it seems to come out of the blue, treatment with medication and/or electroconvulsive 
therapy (ECT) and psychotherapy are necessary. 
 
TYPES OF DEPRESSION: 
Depressive disorders are mood disorders that come in different forms, just as do other 
illnesses, such as heart disease and diabetes. Three of the most common types of depressive 
disorders are discussed below. However, remember that within each of these types, there are 
variations in the number, timing, severity, and  persistence of symptoms. There are also 
differences in how individuals experience depression based on age. 
 
Major depression: 
 
Major depression is characterized by a combination of symptoms that last for at least 
two weeks in a row, including sad and/or irritable mood (see symptom list), that interfere with 
the ability to work, sleep, eat, and enjoy once pleasurable activities. Difficulties in sleeping or 
 
 
eating can take the form of excessive or insufficient of either behavior. Disabling episodes of 
depression can occur once, twice, or several times in a lifetime. 
 
Dysthymia: 
 
Dysthymia is a less severe but usually more long-lasting type of depression compared 
to major depression. It involves long-term (chronic) symptoms that do not disable but yet 
prevent the affected person from functioning at "full steam" or from feeling good. Sometimes, 
people with dysthymia also experience episodes of major depression. This combination of the 
two types of depression is referred to as double-depression. 
 
Bipolar disorder (manic depression): 
 
Another type of depression is bipolar disorder, which encompasses a group of mood 
disorders that were formerly called manic-depressive illness or manic depression. These 
conditions show a particular pattern of inheritance. Not nearly as common as the other types 
of depressive disorders, bipolar disorders involve cycles of mood that include at least one 
episode of mania or hypomania and may include episodes of depression as well. Bipolar 
disorders are often chronic and recurring. Sometimes, the mood switches are dramatic and 
rapid, but most often they are gradual. When in the depressed cycle, the person can experience 
any or all of the symptoms of a depressive disorder. When in the manic cycle, any or all of the 
symptoms listed later in this article under mania may be experienced. Mania often affects 
thinking, judgment, and social behavior in ways that cause serious problems and 
embarrassment. For example, indiscriminate or otherwise unsafe sexual practices or unwise 
business or financial decisions may be made when an individual is in a manic phase. A 
significant variant of the bipolar disorders is designated as bipolar II disorder. (The usual form 
of bipolar disorder is referred to as bipolar I disorder.) Bipolar II disorder is a syndrome in 
which the affected person has repeated depressive episodes punctuated by what is called 
hypomania (mini-highs). These euphoric states in bipolar II do not fully meet the criteria for 
the complete manic episodes that occur in bipolar I. 
 
Postpartum depression: 
 
Postpartum depression (PPD) is a condition that describes a range of physical and 
emotional changes that many mothers can have after having a baby. PPD can be treated with 
medication and counseling. Talk with your health-care practitioner right away if you think you 
have PPD. There are three types of PPD women can have after giving birth 
 
 
1. The so-called "baby blues" happen in many women in the days right after childbirth. 
A new mother can have sudden mood swings, such as feeling very happy and then feeling very 
sad or angry. She may cry for no reason and can feel impatient, irritable, restless, anxious, 
lonely, and sad. The baby blues may last only a few hours or as long as one to two weeks after 
delivery. The baby blues do not always require treatment from a health-care provider. Often, 
joining a support group of new moms or talking with other moms helps. 
 
2. Postpartum depression (PPD) can happen a few days or even months after childbirth. 
PPD can happen after the birth of any child, not just the first child. A woman can have feelings 
similar to the baby blues -- sadness, despair, anxiety, irritability -- but she feels them much 
more strongly than she would with the baby blues. PPD often keeps a woman from doing the 
things she needs to do every day. When a woman's ability to function is affected, this is a sure 
sign that she needs to see her healthcare provider right away. If a woman does not get treatment 
for PPD, symptoms can get worse and last for as long as one year. While PPD is a serious 
condition, it can be treated with medication and counseling. 
 
3. Postpartum psychosis is a very serious mental illness that can affect new mothers. 
This illness can happen quickly, often within the first three months after childbirth. Women 
can experience psychotic depression, in that the depression causes them to lose touch with 
reality, have auditory hallucinations (hearing things that aren't actually happening, like a person 
talking),  and  delusions  (seeing  things  differently  from  what  they are  in  reality).  Visual 
hallucinations (seeing things that aren't there) are less common. Other symptoms include 
insomnia (not being able to sleep), feeling agitated (unsettled) and angry, strange feelings and 
behaviors, as well as having suicidal or homicidal thoughts. Women who have postpartum 
psychosis need treatment right away and almost always need medication. Sometimes women 
are put into the hospital because they are at risk for hurting themselves or someone else, 
including their baby. 
 
DIAGNOSIS  OF DEPRESSION: 
 
People who wonder if they should talk to their health professional about whether or not 
they have depression may consider taking a depression self-test, which asks questions about 
depressive symptoms. In thinking about when to seek medical advice about depression, the 
sufferer can benefit from considering if the sadness lasts more than two weeks or so or if the 
way they are feeling significantly interferes with their ability to function at home, school, or 
work and in their relationships with others. The first step to obtaining appropriate treatment is 
 
 
accurate diagnosis, which requires a complete physical and psychological evaluation to 
determine whether the person may have a depressive illness, and if so, what type. As previously 
mentioned, certain medications, as well as some medical conditions, can cause symptoms of 
depression. Therefore, the examining physician should rule out (exclude) these possibilities 
through an interview, physical examination, and laboratory tests. Many primary-care doctors 
use screening tools, symptoms tests, for depression, which are usually questionnaires that help 
identify people who have symptoms of depression and may need to receive a full mental-health 
evaluation. 
 
The doctor usually asks about alcohol and drug use and whether the patient has had 
thoughts about death or suicide. Further, the history often includes questions about whether 
other family members have had a depressive illness, and if treated, what treatments they 
received and which were effective. 
 
A diagnostic evaluation also includes a mental status examination to determine if the 
patient's speech, thought pattern, or memory has been affected, as often happens in the case of 
a depressive or manic-depressive illness. As of today, there is no laboratory test, blood test, or 
Xray that can diagnose a mental disorder. Even the powerful CT, MRI, SPECT, and PET scans, 
which can help diagnose other neurological disorders such as stroke or brain tumors, cannot 
detect the subtle and complex brain changes in psychiatric illness. However, these techniques 
are currently useful in research on mental health and perhaps in the future they will be useful 
for diagnosis as well. 
 
 
RISK FACTORS 
 
Risk factors of depression 
Lack of social support Social support serves as a protective factor 
 
against depression. People who are isolated 
and have few friends or family members to 
turn to in times of stress are more likely to 
develop depression. 
Recent stressful life experience When people are going through stressful 
 
experiences that overwhelm their coping 
skills, depression often results. 
 
 
 
Previous history of Depression If you’ve had an episode of major 
 
depression before, you are at increased risk 
of having another episode. The probability 
of having a recurrence increases with each 
major depressive episode. 
Family history of Depression If depression runs in your family, your risk 
 
for depression is higher. Your risk is 
particularly high if one of your close 
relatives, such as parent or sibling, had 
depression 
Lower socioeconomic status Research has shown that low socioeconomic 
 
status is associated with increased rates of 
depression. People with lower levels of 
income, education, and occupational status 
face many obstacles and stressors that likely 
contribute to this risk. 
Underlying emotional or personality 
 
Disorder 
People with pervasive emotional difficulties 
 
or personality disorders are vulnerable to 
depression. 
Chronic medical condition Ongoing medical problems or chronic pain 
 
can lead to depression 
Female sex Women are twice as likely to experience 
 
depression as men. 
Advanced age People over the age of 65 are more 
 
vulnerable to depression. 
 
 
 
COMPLICATIONS: 
 
People who are depressed are more likely to use alcohol or illegal substances. 
Complications of depression also include: 
•   Increased risk of physical health problems 
 
•   Suicide 
 
 
Thoughts of Death or Suicide: 
 
People suffering from depression often show distorted thinking. Everything looks bleak 
to them, and they hold extremely negative views about themselves, their situation, and the 
future. Trapped in their pessimism, they brood/obsess over their problems and blow them out 
of proportion. Feeling hopeless and helpless, they may even start to see suicide as their only 
way out. 
 
Suicidal thoughts are a symptom of severe depression and must always be taken 
seriously. If someone you know is threatening suicide or talking of wanting to hurt him/herself, 
seek professional help right away. 
 
PROGNOSTIC FACTORS: 
 
The best predictor of the future course is the history of previous episodes. Not surprisingly, 
the risk of recurrence is much higher in individuals with a history of several previous episodes. 
Other factors that predict a higher risk of future episodes include the following: 
 
 
•   Incomplete symptomatic remission 
 
•   Early age of onset 
 
•   Poor social support 
 
•   Poor physical health 
 
•   Substance abuse 
 
•   Co morbid personality disorder 
 
 
 
The various risk factors, particularly previous pattern of recurrence and the extent of 
current remission, have important implications for the use of longer- term maintenance 
treatments. In many patients, depressive disorders are best conceptualized as chronic relapsing 
conditions that require an integrated longterm treatment approach. 
 
DIFFERENTIAL DIAGNOSIS OF DEPRESSIVE DISORDERS: 
 
Depressive disorders have to be distinguished from the following: 
 
•   Normal sadness 
 
•   Adjustment disorder 
 
•   Anxiety disorders 
 
•   Schizophrenia 
 
•   Organic brain syndromes. 
 
 
PREVENTION: 
 
Do not drink alcohol or use illegal drugs. These substances can make depression worse 
and might lead to thoughts of suicide. 
 
Take your medication exactly as your doctor instructed. Ask your doctor about the 
possible side effects and what you should do if you have any. Learn to recognize the early signs 
that your depression is getting worse. The following tips might help you feel better: 
 
•   Do exercise and Yogam regularly 
 
•   Maintain good sleep habits 
 
•   Seek out activities that bring you pleasure 
 
•   Be a Volunteer or get involved in group activities 
 
•   Talk to someone you trust about how you are feeling 
 
 
DRUG REVIEW 
 
INTERNAL MEDICINE: VENPOOSANI NEI [7] 
 INGREDIENTS:  
 Venpoosanikaai saaru (Benincasa hispida)             -2 Padi (2.6 litres) 
 Thazhai vizhuthu saaru (Pandanus odoratissimus) -1 Padi (1.3 litres) 
 Thennampoo saaru (Cocos nucifera)                       -1 Padi (1.3 litres) 
 Katrazhai saaru (Aloe barbaensis)                           -1 Padi (1.3 litres) 
 Sevvilaneer (Cocus nucifera)                                  -1 Padi (1.3 litres) 
 Cow`s Ghee                                                           -2 Padi (2.6 litress) 
 Cow`s Milk                                                            -2 Padi (2.6 litres) 
 Kaattathippoo (Woodfordia fruticosa)                    -33/4 Varagan (19.6g)                                     
 Seeragam(Cuminam cyminum)           -33/4 Varagan (19.6g) 
 Kothamalli (Coriandrum sativam)          -33/4 Varagan (19.6g) 
 Saathikkaai (Myristica fragrans)                   -33/4 Varagan (19.6g) 
 Maasikaa (Quercus infectoria)          -33/4 Varagan (19.6g) 
 Elam (Elettaria cardamomum)                               -33/4 Varagan (19.6g) 
 Vaalmilagu (Piper nigram)            -33/4 Varagan (19.6g) 
 Sathipathiry (Myristica fragrans)          -33/4 Varagan (19.6g) 
 Kurosani  Omam (Hyoscyamus niger)         -33/4 Varagan (19.6g) 
 Karkadagasingi (Rhus succedanea)          -33/4 Varagan (19.6g) 
 Thriphalai             -33/4 Varagan (19.6g) 
 Palm Sugar                                                              -2 Palam (70g) 
   
 
 
 
 
 
 
  Internal medicine     : Venpoosani Kirutham 
 
Dosage                       : 16 ml, twice a day 
 
Vehicle                       : Sugar or Hot water  
 
Duration of treatment:  48 days 
 
Source :-                   Siddha vaithiya thirattu 
 
EXTERNAL MEDICINE:         SEERAGA ENNAI[8]                                                                                                                                                    
Ingredients:   
 Seeragam (Cynodan dactylon)         -1 Palam(35 gms) 
 Gingelly oil (Sesamum Indicum)     -1 Padi(1.3L) 
 
  METHOD OF PREPARATION: 
 
    Add the both drugs in a large vessel by the given ratio .Gently heat the vessel. When the 
heat reached the optimum level to the cumin seeds scattered and the extracts of that will be 
mixed with oil. Then the oil is filtered and collected the container. 
 
DISPENSING: 
 
•   The Kirutham is given in Pet container (100 gram for one week) 
 
•   Oil is given in pet bottles (Q.S for oil bath). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROPERTIES OF TRIAL DRUGS (INTERNAL MEDICINE) 
 
 
1.Thaazhai 
 
Botanical Name        :  Pandanus odoratissimus        
English Name            :   Fragrant screw - pine 
Family                        :   Pandanaceae 
Part used                       Aerial root  
 
Organoleptic Characters 
 Taste      :      Thuvarppu 
 Potency  :     Thatpam 
 Division  :    Inippu 
 General Property: 
 
ÁÊ§º¡üÈ¡ý Áí¨¸Â÷ìÌ Á¡¾¡ó¾ô âôÀ¡õ 
¦ÅÊîºâ¿ü Àº¢¨Â Å¢¨ÇìÌó- ¾Êò¾Ó¨Ä 
Íì¸¢Äò¨¾ ¦¿ö¨Âò ÐÄÅ¢ìÌï §º¡¨À¦ÂÛõ 
«ìÌÄò¨¾ ¿£ìÌõ «È£ [9] 
 
 
 
 
 
 
 
2.Saathikkai 
Botanical Name :  Myristica fragrans  
English Name     : Nut mug  
Family                 : Myristicaceae  
Part used             :Fruit  
Organoleptic characters  
Taste                    :Thuvarppu 
Potency                :Veppam 
Division               :Karppu 
General property:  
                ¾¡Ð ¿ð¼õ  §À¾¢ ºÕÅ¡º¢  Âïº¢Ã §¿¡ö 
                µÐÍÅ¡ ºí¸¡ºõ ¯ð¸¢Ã½£ -§Å§¾¡ 
                ÊÄì¸¡ö ÅÕõÀ¢½£§À¡õ  ²üÈÁÂø À¢ò¾í 
                ÌÄì¸¡ ÂÕóÐÅ÷ìÌì ÜÚ [9] 
Chemical constituents: 
 Neolignan, 
 Erythrosurinamensin 
 Diaryl phenyl propanoid 
 Virolane  
3.Saathipathiri 
Botanical Name : Myristica fragrans  
English Name     : Arillus of the nut  
Family                :  Myristicaceae 
 
 
 
 
Organoleptic characters  
Taste                    ;Kaarppu, Thuvarppu 
Potency                :Veppam 
Division                :Karppu 
General property:  
º¡¾¢¾Õõ Àò¾¢Ã¢ìÌò ¾¡Àî ÍÃó¾½£Ôõ 
µÐ¸¢ýÈ À¢ò¾õ ¯ÂÕí¸¡ñ -¾¡ÐÅ¢÷ò¾¢ 
Ôñ¼¡í ¸¢Ã¸£½£§Â¡ §¼¡¾ì ¸Æ¢îºÄêõ 
Àñ¼¡í Ì¨È§Â À¸÷ [9] 
Chemical constituents:  
 Neolignan, 
 Erythrosurinamensin 
 Diaryl phenyl propanoid 
 Virolane  
Action  : 
 Carminative 
 Aphrodisiac 
 Stimulant 
4.Maasikkaai 
Botanical Name : Quercus infectoria 
English Name     : Magic Nuts, Oak galls  
Family                :  Fagaceae 
Part used             :Fruit 
 
 
 
 
 
Organoleptic characters  
Taste                    Thuvarppu 
Potency               :Thattpam 
Division                :Kaarppu 
General property:  
         «ì¸Ãí¸û §À¡ì¸¢Å¢Îõ Á¡È¡¾ ¦ÅôÀ¸üÚõ  
         ¦ÁöìÌÕ¾¢ Á¡º¢ì¸¡ö ¦Áý§ÁÖõ- ¾ì¸¦¾¡Õ 
         À¡Ä÷¸½ §¿¡ö §À¡ìÌõ Àý§Á¸ Óó¦¾¡¨ÄìÌõ 
         §ÅÄ¨ÉÂ ¸ñ½¡ö Å¢ÇõÒ [9] 
 
Chemical constituents:   
 Tannin 50–70% , 
 Syringic acid,  
 β-sitosterol,  
 Amentoflavone,  
 Hexamethyl ether,  
 Isocryptomerin,  
 Methyl betulate,  
 Methyl oleanate 
 Hexagalloyl glucose.  
Action  :  
 Astringent  
 Styptic 
 Tonic 
 
 
 
 
5.Thiriphalai 
Botanical Name : Terminalia chebula ,Terminalia bellerica and Phyllanthus embilica 
English Name     : Thripalam 
Family                 :Phyllanthaceae & Combretaceae   
Part used             :Seeds 
Organoleptic characters  
Taste                     Thuvarppu 
Potency               :Veppam 
Division                :Kaarppu 
Chemical constituents: 
 Gallic acid 
 Tannins 
 Palmitic acid  
 Lenoleic acid 
 Oleic acid 
Action  :  
 Astringent 
 Tonic 
 
 
 
 
 
6.Seeragam 
Botanical Name : Cuminum cyminum 
English Name     : cumin seeds or fruits 
Family                : Apiaceae 
Part used             :Seeds 
Organoleptic characters  
Taste                    Thuvarppu, Inippu  
Potency               :Thatppam 
Division                :Inippu 
General property:   
      À¢ò¾¦ÁÛõ Áó¾¢Ã¢¨Âô À¢ýÉô ÀÎò¾¢ÂÅý 
      ºòÐÕ¨Å ÔóÐÈóÐ º¡¾¢òÐ -Áò¾¦ÉÛõ 
      Ã¡ºÉ¨Ô Á£¦Åýê  ¿ñ¨Àô ÀÄôÀÎò¾¢ 
      §À¡ºÉÌ ¼¡Ã¢¦ºÔõ §À¡÷. (§¾Ãý ¦ÅñÀ¡ )  
Chemical constituents:  
 Cuminal (36.31%), 
 Cuminic alcohol (16.92%), 
 γ-terpinene (11.14%), 
 Safranal (10.87%), 
 p-cymene (9.85%) 
 β-pinene (7.75%). 
Action  : 
 Carminative 
 Stomatic 
 Stimulant 
 Astringen 
 
 
7.Elam 
Botanical Name : Elettaria cardamomum  
English Name     :Cardamom seeds 
Family                : Zingiberaceae 
Part used             :Seeds 
Organoleptic characters  
Taste                    Kaarppu 
Potency               :Veppam 
Division               :Kaarppu 
General property:    
         ÁÄÅ¡¾ §Á¡Î ÅÂ¢üêì ¦¸¡¾¢ôÒ 
         ºÄÓÈø Å¡Â¢É¢ôÒ ¾¡¸õ - ºÄ§À¾¢ 
         §Å÷ìÌó  ¾¨Ä§¿¡ö Á¢Ìåð¨º ³ÂÁ¢¨Å 
         §À¡ìÌïº¢ü §ÈÄõ Ò¸ø [9] 
Chemical constituents: 
 α-terpinyl acetate (45.6%), 
 1,8-cineole (26%),  
 Linalyl acetate (5.6%),  
 Linalool (5.2%),  
 α-terpineol(2.9%) 
 Limonene (2.9% ) 
Action  : 
 Carminative 
 Stomachic 
 Stimulant 
 
 
8.Vaalmilagu 
Botanical Name : Piper cubeba 
English Name     : Tail-pepper 
Family                 : Piperaceae 
Part used            : Immature fruit   
Organoleptic characters  
Taste                    Kaarppu,  
Potency               :Veppam 
Division                :Kaarppu 
General property: 
      Å¡¾ À¢ò¾ ³Âõ  ÅÂ¢üê ÅÄ¢¾¡¸ï 
      º£¾õ  ÀÄ§¿¡ö  º¢¨¾Ôí¸¡ñ -§À¡¾ 
      «¾¢¾£ ÀÉÁ¡õ «½í¸Ã§º ¿¡éó 
      Ð¾¢Å¡ø Á¢Ç¸Õó¾î  ¦º¡ø [9] 
Chemical constituents:  
 Monoterpenes (sabinene 50%, carene, α-thujene, 1,4-cineol and 1,8-cineol) 
 
 Sesquiterpenes (copaene, α- and β-cubebene, δ-cadinene, caryophyllene, 
germacrene, cubebol). 
Action  : 
 Carminative 
 Diuretic 
 Expectorant 
 Stimulant 
 
 
9.Kaattathippoo 
Botanical Name : Bauhinia tomentosa 
English Name    : Holy mountain ebony 
Family                 :Fabaceae 
Part used             :Fruit 
Organoleptic characters  
Taste                    Kaarppu, Bitter 
Potency               :Veppam 
Division               :Karppu 
 
General property:   
      ¯¾¢Ãì ¸Îô§À¡ Î¾¢Ãì ¸Æ¢îºø  
      Å¢¾¢Ãì ¸Îõ§À¾¢ §Á¸õ - ±¾¢÷¿¢ü¸ 
      Á¡ð¼¡ ¾¸Öõ ÅÉº ÁÄ÷¾¢Õ§Å 
      ¸¡ð¼¡ò¾¢ô âò¾ÉìÌì ¸¡ñ [9]  
 
Chemical constituents: 
 L-Menthol 
 Rutin 
 Kaempferol 
Action  :  
 Antiperiodic  
 Tonic 
 
 
 
10.Karkadagasingi 
Botanical Name : Rhus succedanea 
English Name     : The galls 
Family                 :Anacardiaceae 
Part used             :unripe fruit 
Organoleptic characters  
Taste                    Thuvarppu,  
Potency               :Veppam 
Division              :Kaarppu 
Chemical constituents: 
 Gallic acid 
 Buetin 
 Beta-caryophyllene 
 
Action  :  
 Astringent 
 Tonic 
 Nutritive 
 Digestive 
 Expectorant 
 Stimulant  
 
 
 
11.Kothamalli 
Botanical Name : Coriandrum sativam 
English Name     : Coriander seeds 
Family                : Apiaceae 
Part used            : Seeds 
 
Organoleptic characters  
Taste                    Kaarppu,  
Potency               :Seedha Veppam 
Division                :Karppu 
 
General property:  
     
         ¦¸¡ò¾ÁøÄ¢ ¦ÅôÀõ ÌÇ¢÷¸¡öîºø À¢ò¾Áó¾ï  
         º÷ò¾¢Å¢ì¸ø ¾¡¸¦Á¡Î ¾¡Ð¿ð¼õ -¸ò¾¢¦ÂÖõ  
         Å¡¾ Å¢¸¡÷Á¼÷ Åý¸÷ò¾ À¢Å¢Ã½õ  
         â¾Äò¾¢ø Å¡¾¸üÚõ  §À¡üÚ [9] 
Chemical constituents: 
 Linalool 
 Geranyl acetate 
 Caryophyllene 
 Cymene 
Action  : 
 Carminative 
 Diuretic 
 Stomachic 
 Stimulant 
 
 
12.Kurosaani Omam 
Botanical Name : Hyoscyamus niger 
English Name     : Henbaneseeds 
Family                 :Solanaceae 
Part used            : Seeds 
Organoleptic characters  
Taste                    Karppu, Siru kaippu 
Potency               :Veppam 
Division               :Kaarppu 
Chemical constituents: 
 Hyoscyamine 
 Scopalamine 
 Atropine 
 Hyoscyamide 
 Cannabisin D 
 Rutin 
 Beta-Sitosterol 
 Venkatasin 
Action  :  
 Hypnotic 
 Sedative 
 Anodyne 
 Anispasmodic 
 
 
13.Thennai 
Botanical Name : Cocos nucifera 
English Name     : Coconut tree 
Family                 : Arecaceae 
Part used             : coconut flower juice 
Organoleptic characters 
Taste                    Thuvarppu,  
Potency               :Thadpam 
Division              :Inippu 
General property:  
 
          §Á¸õ «¸ì¦¸¡¾¢ôÒ  Å£ÚÅ¢ Ãò¾ôÀ¢ò¾õ  
          §Å¸ «º¢÷ì¸Ã§¿¡ö  Å£ØÀ¢ÃÁ¢ - §¾¸ò¾¢ø 
          Å¢ýÉõÀ¡Ä¢ìÌõ Å¢¼À¡¸õ §À¡¸¦ÅýÈ¡ø 
          ¦¾ýÉõÀ¡¨Çôâ¨Åò ¾¢ý [9] 
 
Action  :  
 Refrigerant  
 Stomachic 
 Demulcent 
 
 
 
 
 
13.Kattraazhai 
Botanical Name  : Aloe Barbadensis 
English Name     : Indian aloes  
Family                 : Asphodelaceae 
Part used             :Latex,Pulp Extract  
Organoleptic characters  
Taste                   :Siru kaippu,  
Potency               :Thatpam 
Division               :Inippu 
General property:  
            ÅüÈ¡ì ÌÁÃ¢¾ý¨É ÅüÈ¡¦ÄÉ ×ñ½¢Ûïº£÷  
           ÓüÈ¡ì ÌÁÃ¢¦ÂÉ ãé§Á - ¿üÈ¡ìÌó 
           ¾¢ñ¨ÁÔ ÁøÄ¡ò ¦¾Ã¢¨ÅÂ§ÁÂ¡É¡Ö  
           Óñ¨ÁÁ¢Ì áÈ¡Á¡ Ôû [9] 
Chemical constituents: 
 Aloin 
 Emodin 
 Campesterol 
 Beta Sitosterol 
 Auxines 
 Gibberellines 
 Lignin 
 Glucomannon 
Action  :   
 Tonic 
 Alterative 
 Purgative 
 
 
1. MATERIALS AND METHODS 
 
STANDARD OPERATING PROCEDURE 
        The required raw drugs for the trial medicine had purchased from a well reputed 
country raw drug shop and drugs were authenticated by the competent authority 
Medicinal Botany and Gunapadam dept. After that the raw drugs had purified as per 
siddha literatures then the trial drug s prepared in Gunapadam laboratory of National 
Institute of Siddha. 
 
BOTANICAL AUTHENTICATION CERTIFICATE NO: NISMB3612019 
 
INTERNAL MEDICINE: VENPOOSANI NEI 
 INGREDIENTS:  
 Venpoosanikaai saaru (Benincasa hispida)                -2 Padi (2.6 litres) 
 Thazhai vizhuthu saaru (Pandanus odoratissimus)    -1 Padi (1.3 litres) 
 Thennampoo saaru (Cocos nucifera)                         -1 Padi (1.3 litres) 
 Katrazhai saaru (Aloe barbaensis)                             -1 Padi (1.3 litres) 
 Sevvilaneer (Cocus nucifera)                                      -1 Padi (1.3 litres) 
 Cow`s Ghee                                                             -2 Padi (2.6 litres) 
 Cow`s Milk                                                              -2 Padi (2.6 litres) 
 Kaattathippoo (Woodfordia fruticosa)            -33/4 Varagan (19.6g)                                     
 Seeragam(Cuminam cyminum)                       -33/4 Varagan (19.6g) 
 Kothamalli (Coriandrum sativam)          -33/4 Varagan (19.6g) 
 Saathikkaai (Myristica fragrans)      -33/4 Varagan (19.6g) 
 Maasikaai (Quercus infectoria)      -33/4 Varagan (19.6g) 
 Elam (Elettaria cardamomum)                      -33/4 Varagan (19.6g) 
 
 
 Vaalmilagu (Piper nigram)                   -33/4 Varagan (19.6g) 
 Sathipathiry (Myristica fragrans)      -33/4 Varagan (19.6g) 
 Kurosani  Omam (Hyoscyamus niger)     -33/4 Varagan (19.6g) 
 Karkadagasingi (Rhus succedanea)      -33/4 Varagan (19.6g) 
 Thriphalai         -33/4 Varagan (19.6g) 
 Palm Sugar                                                            -2 Palam (70g) 
 
METHOD OF PURIFICATION OF RAW DRUGS[10]: 
 
Purification of Kumari: 
         To be Boiled with the Cow Milk 
Purification of Aavin nei: 
         To be Boiled until removal of water 
Purification of Sathikkaai: 
        To be removed the outer layer and Dry in sun light 
Purification of Sathipathiri: 
       To be dried in Sun light            
Purification of Thriphalai: 
      To be removed the inner part(seed) of each herb and  take the outer part 
 
Purification of Seeragam: 
          It will be dried in the Sun light 
Purification of Elam: 
        It to be Roasted 
Purification of Vaalmilagu: 
           To be removed the stems and Dry in sun light 
Purification of Kaattathippoo: 
         To be removed the petals and stems and Dry in sun light  
Purification of Karkadagasingi: 
        To be Fried with the Vaathumai Ghee 
 
 
Purification of Kothamalli: 
       To be dried in shadow  
  
Purification of Kurosani omam: 
        To be removed the Dust and Soil by Filteration          
Purification of Seeni Karkandu: 
        To be powdered as fine molecules 
 
 
METHOD OF PREPARATION: 
 
   Initially all the plant extracts and juices exept the raw drugs had taken in a large 
vessel as per the given amount. Then, all other contents except cow`s milk and sugar were 
powdered into fine particles. These powder  grinded with the cow`s milk and then it mixed 
with the cow`s milk by the given ratio. Then, the mixture mixed into the vessel. Then,it 
gently heated for optimum temperature.  And,when the perfect term came it had taken 
away and mixed with the sugar as per the given ratio. Then,had transferred into pet 
container. 
  
 
 
EXTERNAL MEDICINE:         SEERAGA ENNAI                                                                                                                                                    
Ingredients:   
 Seeragam (Cynodan dactylon)         -1 Palam(35 gms) 
 Gingelly oil (Sesamum Indicum)     -1 Padi(1.3L) 
  METHOD OF PREPARATION: 
 
    Both drugs were added  in a large vessel by the given ratio .Gently heat the vessel. 
When the heat reached the optimum level to the cumin seeds scattered and the extracts of 
that had mixed with oil. Then the oil had filtered and collected the container. 
 
DISPENSING: 
 
•   The Kirutham is given in Pet container (100 gram for one week) 
 
•   Oil is given in pet bottles (Q.S for oil bath). 
 
 
       
 Benincasa hispida       Aloe barbaensis 
 
         
  Cocus nucifera    Cocus nucifera  
   
                  
         Terminalia bellerica                           Myristica Fragrans   
 
 
                   
 Terminalia chebula     Phyllanthus embilika 
     
      
Woodfordia fruticosa             Elettaria Cardamomum 
                         
Myristica Fragrans      Coriandrum sativum 
 
 
             
    Quercus infectoria    Hyoscyamus nigra   
 
             
      Piper nigram       Cuminum cyminum 
 
                    
     Pandanus odorattismus            Ghee 
 
 
 
                   
          Palm Sugar                                Milk 
   
 
                                                             Venpoosani Nei 
 
                            Seeraga Thylam 
 
 
 
 
BIO CHEMICAL EVALUATION 
 
Experimental procedure 
 
5 g of VENPOOSANI KIRUTHAM was taken in a 250 ml of clean beaker and 
50ml of distilled water was added to it. Then it was boiled well for about 10 min. Then it 
is allowed to cool and filtered in a 100 ml volumetric flask and made up to 100 ml with 
distilled water. This preparation is used for the qualitative analysis of acidic/ basic 
radicals and biochemical constituents in it. 
 
Preparation of extract 
 
5gm of VENPOOSANI KIRUTHAM was weighed accurately and placed in a 
250ml clean beaker and 50ml of distilled water was added with it. Then it was boiled 
well for about 10 minutes. Then it was allowed to cool and filtered in a 100ml volumetric 
flask and made up to 100ml with distilled water. The bio-chemical analysis of 
VENPOOSANI KIRUTHAM was done at Biochemistry lab, National Institute of siddha, 
Chennai-47. 
 
Preliminary test for Copper, Sodium, Silicate and Carbonate 
 
 Test for Silicate: a. A little (500mg) of the sample is shaken well with distilled water.  
b. A little (500mg) of the sample is shaken well with con. HCl/Con. H2So4. 
 Action of Heat: A small amount (500mg) of the sample is taken in a dry test tube and 
      heated gently at first and then strong. 
 Action of Heat: A small amount (500mg) of the sample is taken in a dry test tube and 
heated gently at first and then strong. 
 Flame Test: A small amount (500mg) of the sample is made into a paste with con. HCl 
in a watch glass and introduced into non-luminous part of the Bunsen flame. 
 Ash Test: A filter paper is soaked into a mixture of sample and dil. cobalt nitrate 
solution and introduced into the Bunsen flame and ignited. 
 
Test for Acid Radicals 
 
 Test for Sulphate: 2ml of the above prepared extract was taken in a test tube and 2ml 
of 4% dil. ammonium oxalate solution was added. 
 Test for Chloride: 2ml of the above prepared extracts was added with 2ml of dil-HNO3 
until the effervescence ceases off. Then 2 ml of silver nitrate solution was added. 
 
 
➢  Test for Phosphate: 2ml of the extract was treated with 2ml of con. HNo3 and 2ml of 
dil. ammonium molybdate solution. 
➢  Test for Carbonate: 2ml of the extract was treated with 2ml dil. magnesium sulphate 
solution 
➢  Test for Nitrate:1gm of the substance was heated with copper turning and concentrated 
H2SO4 and viewed the test tube vertically down. 
➢  Test for Sulphide: 1gm of the substance was treated with 2ml of con. HCL 
➢  Test for Fluoride & Oxalate: 2ml of extract was added with 2ml of dil. Acetic acid 
and 2ml dil. calcium chloride solution and heated. 
➢  Test for Nitrite: 3drops of the extract was placed on a filter paper, on that-2 drops of 
dil. acetic acid and 2 drops of dil. Benzidine solution were placed. 
 
Test for Basic Radicals 
➢  Test for Lead: 2ml of the extract was added with 2ml of dil. potassium iodine solution. 
➢  Test for Copper: One pinch (50mg) of substance was made into paste with con. HCl 
in a watch glass and introduced into the non-luminous part of the flame. 
➢  Test for Aluminium: In the 2ml of extract dil. sodium hydroxide was added in 5 drops 
to excess. 
➢  Test for Iron: a. To the 2ml of extract add 2ml of dil. ammonium solution 
➢  b. To the 2ml of extract 2ml thiocyanate solution and 2ml of con HNo3 is added 
➢  Test for Zinc: In 2ml of the extract dil. sodium hydroxide solution was added in 5 drops 
to excess and dil. ammonium chloride was added. 
➢  Test for Calcium: 2ml of the extract was added with 2ml of 4% dil. ammonium oxalate 
solution 
➢  Test for Magnesium: In 2ml of extract dil. sodium hydroxide solution was added in 
drops toexcess. 
➢  Test for Ammonium: In 2ml of extract 1 ml of Nessler's reagent and excess of dil. 
sodium hydroxide solution were added. 
➢  Test for Potassium: A pinch (25mg) of substance was treated with 2ml of dil. sodium 
nitrite solution and then treated with 2ml of dil. cobalt nitrate in 30% dil. glacial acetic 
acid. 
➢  Test for Sodium: 2 pinches (50mg) of the substance was made into paste by using HCl 
and introduced into the blue flame of Bunsen burner. 
 
 
➢  Test for Mercury: 2ml of the extract was treated with 2ml of dil. sodium 
hydroxide solution. 
➢  Test for Arsenic: 2ml of the extract was treated with 2ml of dil. sodium 
hydroxide solution. 
 
Other constituents: 
➢  Test for Starch: 2ml of extract was treated with weak dil. iodine solution 
➢  Test for Reducing Sugar: 5ml of Benedict's qualitative solution was taken in a 
test tube and allowed to boil for 2 minutes and added 8 to 10 drops of the extract and 
again boil it for 2 minutes. 
➢  Test for The Alkaloids:  
a) 2ml of the extract is treated with 2ml of dil. Potassium iodide solution.     
b) 2ml of the extract is treated with 2ml of dil. picric acid. 
➢  Test for Tannic Acid: 2ml of extract was treated with 2ml of dil. ferric 
chloride solution 
➢  Test  for  Unsaturated  Compound:  In  the  2ml  of  extract  2ml  of  dil.  
Potassium permanganate solution was added. 
➢  Test for Amino Acid: 2 drops of the extract were placed on a filter paper and 
dried well, and then 20 ml of Burette reagent was added in it. 
 
CLINICAL STUDY 
 
Clinical trail Approval Registration 
 
The clinical trail was approved by the Institutional Ethical Committee (IEC) of 
National Institute of Siddha, Chennai 47, [ NIS/13-IEC/2017-1-05/22-11-2017] and 
further registered Clinical Trail Registry of India [REG. NO. CTRI/2018/08/021389]. 
 
 
Study type     :              An open clinical trial 
 
Study place    :           OPD of Ayothidoss Pandithar 
Hospital, National Institute of Siddha 
Tambaram sanatorium, Chennai-47 
 
Study period :           2016-2019 
 
Sample size    :             30 Patients 
 
 
 
 
 
 
SUBJECT SELECTION: 
 
 
Patients reporting with symptoms of inclusion criteria have subjected to screening 
test and documentation. 
 
INCLUSION CRITERIA 
 
➢  Age: between 20 years and 60 years 
➢  Sex: Male and female 
➢  Depressed mood 
➢  Reduced level of interest 
➢  Considerable loss or gain of weight 
➢  Insomnia or hypersomnia 
➢  Psychomotor agitation or retardation 
➢  Fatigue 
➢  Thoughts of extreme guilt 
➢  Diminished ability to think or concentrate 
➢  Willing to participate in trial and signing consent by fulfilling the conditions 
of proforma 
➢  Willing to give blood sample for analysis for laboratory investigations 
 
 
EXCLUSION CRITERIA 
➢  Pregnancy and lactation 
➢  Diabetes mellitus 
➢  Psychosomatic disorders 
➢  Cardiac disease 
➢  Any other serious systemic illness 
 
WITHDRAWAL CRITERIA 
➢  Intolerance to the drug and development of adverse reactions during drug trial. 
➢  Poor patient compliance and defaulters. 
➢  Patient turning unwilling to continue in the course of clinical trial. 
➢  Occurrence of any serious illness 
➢  Increase in the severity of the symptoms. 
 
 
 
 
 
 
 
 
TESTS AND ASSESMENTS 
 
1. Clinical assessment 
 
2. Siddha system assessment 
 
3. Routine investigations 
 
1. CLINICAL ASSESMENT 
➢  Depressed mood 
➢  Reduced level of interest 
➢  Considerable loss or gain of weight 
➢  Insomnia or hypersomnia 
➢  Fatigue 
➢  Thoughts of extreme guilt 
➢  Suicidal thoughts 
2. GRADATION 
 
 Patient’s Name 
 
 Date of Assessment 
 
To rate the severity of depression in patients who are already diagnosed as 
depressed, administer this questionnaire.  The higher the score, the more severe the 
depression. 
 
     Beck' s Depression Inventory  
This depression inventory can be self-scored. The scoring scale is at the end of the 
questionnaire.  
1.  
0  I do not feel sad.  
1   I feel sad  
2  I am sad all the time and I can't snap out of it.  
 
 
3  I am so sad and unhappy that I can't stand it.  
2.  
0  I am not particularly discouraged about the future.   
1   I feel discouraged about the future.   
2  I feel I have nothing to look forward to.  
3  I feel the future is hopeless and that things cannot improve.  
 
3.  
0 I do not feel like a failure.  
1   I feel I have failed more than the average person.  
2  As I look back on my life, all I can see is a lot of failures.  
3  I feel I am a complete failure as a person.  
 
4.  
    0 I get as much satisfaction out of things as I used to.  
            1  I don't enjoy things the way I used to.  
            2  I don't get real satisfaction out of anything anymore.  
            3  I am dissatisfied or bored with everything.  
 
5.  
           0   I don't feel particularly guilty  
           1  I feel guilty a good part of the time.  
           2  I feel quite guilty most of the time.  
           3  I feel guilty all of the time.  
           6. 
          0   I don't feel I am being punished.  
          1  I feel I may be punished.  
          2  I expect to be punished.  
          3  I feel I am being punished.  
7.  
         0   I don't feel disappointed in myself.  
         1  I am disappointed in myself.  
         2  I am disgusted with myself.  
         3  I hate myself.  
 
 
8.  
         0   I don't feel I am any worse than anybody else.  
         1  I am critical of myself for my weaknesses or mistakes.  
         2  I blame myself all the time for my faults.  
         3  I blame myself for everything bad that happens.  
9.  
       0    I don't have any thoughts of killing myself.  
       1   I have thoughts of killing myself, but I would not carry them out.  
       2   I would like to kill myself.   
       3  I would kill myself if I had the chance.  
 
10.  
       0    I don't cry any more than usual.  
       1   I cry more now than I used to.  
       2   I cry all the time now.  
       3   I used to be able to cry, but now I can't cry even though I want to  
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       0   I am no more irritated by things than I ever was.  
       1   I am slightly more irritated now than usual.  
       2   I am quite annoyed or irritated a good deal of the time.  
       3   I feel irritated all the time.  
 
 
12.  
        0    I have not lost interest in other people.  
        1   I am less interested in other people than I used to be.  
        2   I have lost most of my interest in other people.  
        3   I have lost all of my interest in other people.  
 
13.  
        0    I make decisions about as well as I ever could.  
        1   I put off making decisions more than I used to.  
        2   I have greater difficulty in making decisions more than I used to.  
        3   I can't make decisions at all anymore.  
 
 
14.  
        0    I don't feel that I look any worse than I used to.  
        1   I am worried that I am looking old or unattractive.  
        2   I feel there are permanent changes in my appearance that make me look     
                        unattractive  
        3    I believe that I look ugly.  
15.  
        0    I can work about as well as before.  
        1   It takes an extra effort to get started at doing something.  
        2   I have to push myself very hard to do anything.  
        3   I can't do any work at all.  
 
 
16.  
        0    I can sleep as well as usual.  
        1   I don't sleep as well as I used to.  
        2   I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.  
        3   I wake up several hours earlier than I used to and cannot get back to sleep.  
17.  
       0    I don't get more tired than usual.  
       1   I get tired more easily than I used to.  
       2   I get tired from doing almost anything.  
       3   I am too tired to do anything.  
18.  
       0    My appetite is no worse than usual.  
       1  My appetite is not as good as it used to be.  
       2   My appetite is much worse now.  
       3   I have no appetite at all anymore.  
 
19.  
      0    I haven't lost much weight, if any, lately.  
      1  I have lost more than five pounds.  
      2   I have lost more than ten pounds.  
      3   I have lost more than fifteen pounds.   
 
 
 
 20.  
      0   I am no more worried about my health than usual.  
      1   I am worried about physical problems like aches, pains, upset stomach, or    
             constipation.  
      2   I am very worried about physical problems and it's hard to think of much else.  
      3   I am so worried about my physical problems that I cannot think of anything 
else.   
 
21.  
      0    I have not noticed any recent change in my interest in sex.  
      1   I am less interested in sex than I used to be.  
      2   I have almost no interest in sex.  
      3   I have lost interest in sex completely. 
 
 
INTERPRETING THE BECK DEPRESSION INVENTORY  
Now that you have completed the questionnaire, add up the score for each of the 
twenty-one questions by counting the number to the right of each question you 
marked. The highest possible total for the whole test would be sixty-three. This would 
mean you circled number three on all twenty-one questions. Since the lowest possible 
score for each question is zero, the lowest possible score for the test would be zero. 
This would mean you circles zero on each question.  
You can evaluate your depression according to the Table below.  
Total Score______________ Levels of Depression  
1-10____________________These ups and downs are considered normal   
11-16___________________Mild mood disturbance   
17-20___________________Borderline clinical depression   
21-30___________________Moderate depression   
31-40___________________Severe depression   
over 40_________________ Extreme depression 
 
 
 
 
 
2.INVESTIGATIONS BASED ON SIDDHA SYSTEM: 
 
1. Naadi 
 
2. Sparisam 
 
3. Naa 
 
4. Niram 
 
5. Mozhi 
 
6. Vizhi 
 
7. Malam 
 
8.Moothiram 
 
● Neerkkuri:                                          ● Neikkuri: 
 
3.INVESTIGATION: 
BLOOD: 
•   Hb 
 
•   Total WBC Count 
 
•   DC 
▪      Polymorphs 
▪      Lymphocytes 
▪      Eosinophils 
▪      Monocytes 
▪      Basophils 
 
•   Total RBC count 
 
 
 ESR 
 
 
▪      ½ Hr:                    1 Hr: 
 
•   Blood sugar 
▪      Fasting:       PP: 
 
•   Serum cholesterol 
 
URINE 
 
•   Albumin 
 
•   Sugar(F)                          (PP) 
 
•   Deposits 
 
RENAL FUNCTION TESTS 
 
•   Blood Urea 
 
•   Serum Creatinine 
 
•   Uric acid 
 
 
LIVER FUNCTION TESTS 
 
•   Serum total bilirubin 
 
•   Direct bilirubin 
 
•   Indirect bilirubin 
 
•   Serum Alkaline phosphatases 
 
•   SGOT 
 
•   SGPT 
 
 
PRIMARY OUTCOME: 
 
 
•   Reduction in the symptoms of Depression. 
 
 
DATA COLLECTION: 
 
Required information were collected from each patient by using the following forms 
 
 
FORMS: 
 
•   FORM I         -     Screening and selection Proforma 
 
•   FORM II        -    Clinical assessment Proforma 
 
•   FORM III        -    Laboratory investigation Proforma 
 
 
 
•   FORM IV        -    Drug compliance form 
 
•   FORM V         -    Patient information sheet 
 
 
•   FORM VI      -    Consent form 
•   FORM VII      -  Withdrawal form/Pharmacovigilance 
                  •   FORM VIII    -    Dietary Advice form 
 
STUDY ENROLLMENT: 
 
➢  In this study, patients reporting at the OPD with symptoms of depressed mood, fatigue, 
loss of interest, suicidal thoughts, insomnia, hypersomnia were examined clinically for 
enrolling in the study based on inclusion and exclusion criteria. 
➢  The patients who were enrolled were informed (Form VI) about the study, trial 
drug, possible  outcomes  and  the  objectives  of  the  study  in  the  language  and  
terms understandable to them and the informed consent would be obtained in writing 
from them in the consent form (Form VI). 
➢  All these patients were given unique registration card in which the patients Registration 
number of the study, Address, Phone number and Doctors phone number etc. had 
given, so as to report easily should any complications arise. 
➢  Complete clinical history, complaints, duration, examination findings and laboratory 
investigations -- were recorded in the prescribed Proforma. 
➢  Screening Form- I were filled up: Form –II and Form –III were used for recording the 
patient’s history, clinical examination of symptoms, signs and laboratory investigations 
respectively. Patients were advised to take the trial drug and appropriate dietary advice 
would be given according to the patients’ perfect understanding. 
 
CONDUCT OF THE STUDY: 
 
➢ Before the treatment, purgation therapy had given with Agasthiyar Kuzhambu 200mg  in 
the early morning with Inji chaaru (ginger juice) for normalizing the vital humors. 
 
 Then the trial Medicines “Venpoosani kirutham” (internal) and “Seeraga Thylam” 
(external) was given for 48 days. 
 
➢ The patients were requested to visit the hospital OPD once in 7 days for 48 days. In each 
and  every visit  the  patients  received  trial  medicines  and  also  underwent  clinical 
assessment  and  the prognosis  were recorded  with  the supervision  of the Faculty 
member. 
 
 
 
➢   Laboratory investigations were done before and after the trial. At the end of the trial, 
the patients were advised to visit the OPD for further 2 months for follow-up for any 
recurrence. Defaulters had not allowed to continue and withdrawn from the study with 
fresh case had being inducted. 
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ADVERSE/SERIOUS EFFECTS MANAGEMENT: 
 
➢  In this study, no adverse events were observed during the course of the treatment and 
follow-up periods. 
 
DATA ANALYSIS: 
 
➢  After enrolled the patients in the study, a separate file for each patient was maintained 
and all forms were kept in the file. 
➢  Study number and patient’s number were entered on the top of the file for easy 
identification. 
➢  Whenever the patients visit to OPD during the study period, the necessary entries were 
made at the assessment forms. 
➢  The screening forms were filled separately. 
➢  All forms were further scrutinized by Senior Research Officer (Statistics) for logical 
errors and incompleteness of data to avoid any bias. 
➢  No modification in the results is permitted for unbiased reports. The software of SPSS 
used for data analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS OF PRECLINICAL STUDY: 
 
 
1) BIO-CHEMICAL AND ELEMENTAL ANALYSIS OF TRIAL MEDICINE 
Qualitative Analysis 
S.NO EXPERIMENT OBSERVATION INFERANCE 
1. Appearance of the sample Greenish Brown in 
 
Colour 
 
2. Solubility 
 
a. A little of the sample is shaken 
well with distilled water. 
b. A little of the sample is Shaken 
well with con. Hcl Con. H2SO4. 
Completely soluble 
 
 
 
 
 
Completely soluble 
Presence of Silicate 
3. Action of Heat 
 
A small amount of the sample 
is taken in a dry test tube and heated 
gently at first and then Strong. 
White fumes not 
evolved Brown 
fumes not evolved 
Absence of 
Carbonate. 
Absence of Nitrate 
4. Flame Test 
 
A small amount of the sample 
is made into a paste with con. Hcl in 
a watch glass and introduced into 
non-luminous part of the Bunsen 
flame. 
White flame is 
 
Appeared 
Absence of Copper 
5. Ash Test 
 
A filter paper is soaked into a 
mixture of sample and cobalt nitrate 
solution and introduced into the 
Bunsen flame and ignited 
No Yellow colour 
 
Flame 
Absence of Sodium. 
 
 
PREPARATION OF EXTRACT 
 
5 gm of VENPOOSANI KIRUTHAM was weighed accurately and placed in a 250 ml 
clean beaker. Then 50 ml distilled water was added and dissolved well. Then it is boiled well 
for about 10 minutes. It was cooled and filtered in a 100 ml volumetric flask and then it was 
made up to 100 ml with distilled water. This fluid was taken for analysis. 
 
1.TEST FOR ACID RADICALS: 
 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1. Test for Sulphate: 
  
a. 2 ml of the above prepared 
extract is taken in a test tube to 
this added 2ml of 4% ammonium 
oxalate solution. 
b. 2ml of the above prepared 
extract is added with 2 ml of 
dilHcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution is 
added. 
Cloudy appearance 
 
present 
 
 
 
A white precipitate 
insoluble in con. Hcl 
is obtained 
Absence of sulphate 
2. Test for Chloride: 
 
2 ml of the above prepared 
Extract is added with dil. HNO3 
till the effervescence ceases. Then 
2 ml of silver nitrate solution is 
added. 
Cloudy 
 
appearance present 
 
(Mild trace element) 
Presence of chloride 
3. Test for Phosphate: 
 
2 ml of the extract is treated 
with 2ml of ammonium 
molybdate solution and 2 ml of 
con. HNO3 
Cloudy yellow 
 
Appearance abscent 
Absence of 
 
Phosphate 
4. Test for Carbonate: cloudy appearance Presence of 
 
Carbonate. 
  
 2m1 of the extract is treated 
 
with 2ml magnesium sulphate 
solution 
  
5. Test for Nitrate: 
 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4   and viewed 
the test tube vertically down. 
No characteristic 
changes  
Absence of nitrate 
6. Test for Sulphide: 
 
1 gm of the substance is treated 
with 2m1 of con. Hcl. 
No rotten egg 
 
smelling gas evolved 
Absence of sulphide 
7. Test for Fluoride and oxalate: 
 
2 m1 of The Extract Is Added 
 
With 2m1of Acetic Acid and 2 
 
m1 calcium Chloride solution and 
heated. 
No cloudy appearance Absence of fluoride 
 
and oxalate 
8. Test for Nitrate: 
 
3 drops of extract is placed on a 
filter paper, on that 2 drops of 
acetic Acid and 2 drops of 
benzidine solution is placed. 
No characteristic 
changes 
Absence of nitrate 
9. Test for Borate: 
 
2 pinches of the substance are 
made into paste by using 
sulphuric acid and alcohol (95%) 
and introduced into the blue flame 
No characteristic 
changes 
Absence of borate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 II. TEST FOR BASIC RADICALS 
 
S.no EXPERIMENT OBSERVATION INFERENCE 
1. Test for Lead: 
 
2 m1of the extract is added 
with 2m1of potassium iodide 
solution. 
Yellow precipitate 
 
is obtained 
Presence of Lead. 
2. Test for Copper: 
 
a. One pinch of substance is 
made into paste with con. Hcl in a 
watch glass and introduced into the 
non-luminous part of the flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
Blue colour flame 
 
Precipitate not formed 
 
 
 
 
 
No Blue colour 
precipitate 
Absence of Copper. 
 
 
 
 
 
 
 
Absence of Copper. 
3. Test For Aluminium: 
 
Take the 2m1of the extract 
sodium hydroxide is added in drops 
to excess. 
 characteristic 
changes present 
Presence of 
 
Aluminium. 
4. Test  For Iron (Ferrous) : 
 
To the 2 ml of extract 2m1 
ammonium thiocyanate solution 
and 2m1of con.HNO3 is added. 
Blood red colour 
 
Appearance present 
Presence of Iron. 
5. Test For Zinc: 
 
To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
White precipitate is 
 
 Formed 
Presence of Zinc. 
6. Test For Calcium: 
 
To  2m1 of the extract is 
added with 2m1 of 4% ammonium 
oxalate Solution. 
Cloudy appearance 
 
and white precipitate 
is obtained 
Absence of Calcium 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7. Test For Magnesium: 
 
To 2ml of extract sodium 
hydroxide solution is added in 
drops to excess. 
White precipitate is 
 
 obtained. 
Presence of 
 
Magnesium 
8. Test For Ammonium: 
 
To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added 
 Brown colour 
 
Appeared 
Presence of 
 
Ammonium 
9. Test For Potassium: 
 
A pinch of substance is 
treated with 2ml of sodium nitrite 
solution and then treated with 
2m1 of cobalt nitrate in 30% 
 
glacial acetic acid. 
No Yellowish 
precipitate 
 
is obtained 
Absence of 
 
Potassium 
10. Test For Sodium: 
 
2 pinches of the substance is 
made into paste by using HCL 
and introduced into the blue flame 
of Bunsen burner. 
No Yellow Color 
 
Flame appeared. 
Absence of Sodium. 
11. Test For Mercury: 
 
2 m1 of the extract is treated 
with 2ml of sodium hydroxide 
solution. 
Yellow precipitate 
is not obtained 
Absence of Mercury. 
12. For Arsenic Test: 2 m1 of the 
extract is treated with 2m1 of 
sodium hydroxide solution. 
No brownish red 
 
Precipitate is obtained 
Absence of Arsenic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 III. MISCELLANEOUS: 
 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1. Test for Starch: 
 
2 ml of extract is treated 
with weak iodine solution. 
blue colour developed Presence of Starch. 
2. Test For Reducing Sugar: 
 
5 ml of Benedict's 
qualitative solution is taken in a 
test tube and allowed to boil for 2 
minutes and added 8 to 10 drops 
of the extract and again boil it for 
2 minutes. The colour changes are 
noted. 
Brick red colour 
not developed 
Absence of 
 
Reducing sugar. 
3. Test For The Alkaloids: 
 
a. 2m1 of the extract is treated 
with 2 ml of potassium Iodide 
solution.                       b. 2m1 of 
extract is treated with 2ml of 
picric acid. c. 2m1 of the extract is 
treated with 2ml of 
phosphotungstic acid. 
Red colour developed 
Trace Yellow colour 
developed White 
precipitate developed 
Presence of 
 
Alkaloid. 
 
 
 
Trace of Alkaloid 
present. Presence of 
Alkaloid. 
4. Test for Tannic Acid:  2 ml of 
 
extract is treated with  2ml of 
ferric chloride solution. 
Black precipitate is not  
 
Obtained 
Absence of tannin 
5. Test for Unsaturated Compound: 
 
To the 2ml of extract 2ml of 
Potassium Permanganate solution 
is added. 
Potassium 
 
Permanganate is not 
decolourised 
Absence of 
 
Unsaturated 
 
Compound. 
6. Test For Amino Acid: 
 
2 drops of the extract is placed 
on a filter paper and dried well 
and 2 ml of biuret reagent is 
added . 
No Violet colour 
 
Developed 
Absence of Amino 
 
Acids 
  
7. Test For type of Compound:   2ml 
 
of the extract is treated with 2 ml 
of ferric chloride solution. 
No Green colour 
 
developed 
 
 
 
 
 
No Red colour 
developed 
 
 
 
 
 
 
No Violet colour 
developed 
 
 
 
 
No blue colour 
developed 
Absence of oxy 
 
quinole epinephrine 
and pyro catechol. 
 
 
Anti pyrine, 
Aliphatic 
amino acids and 
Meconic acid are 
absent. 
 
 
Apomorphine, 
Salicylate and 
Resorcinol are 
absent. 
 
 
Morphine, Phenol 
cresol and hydro 
quinone are absent 
 
 
 
Result: 
 
The bio chemical analysis of VENPOOSAN KIRUTHAM shown the presents of 
Chloride, carbonate,magnesium,ammonium, aluminium,lead,zinc, iron, starch, alkaloids.
 2. OBSERVATION AND RESULTS CLINICAL STUDY 
  
The observation and results were studied and tabulated under the following heading. 
 
➢  Age and sex 
➢  Occupational Status 
➢  Family History 
➢  Diet Habits 
➢  Thinai Reference 
➢  Kaalam Distribution 
➢  Yakkai Ilakkanam (Physical Constitution) 
➢  Gunam 
➢  Duration of Illness 
➢  Distributions of Muthodam (Three Humors) 
➢  Udal Kattukkal 
➢  En Vagai Thervugal 
➢  Neerkkuri, Neikkuri 
➢  Haematology General report 
➢  Haematology Biochemistry report 
➢  Urine Analysis 
➢  Result and Statistical Significance of BECK DEPRESSION SCALE score 
➢  Result and Statistical significance of trail medicine.
 1. Age Distribution: 
S.NO AGE NO OF CASES PERCENTAGE 
1. 20-30 10 33.3% 
2. 31-40 11 36.6% 
3. 41-50 7  23.3% 
4. 51-60 2 6.6% 
Total  30 100% 
 
 
   AGE 
 
 
Observation:   The patients were selected from all age groups as given above and the 
maximum numbers of patients 11(36.6%) were in the age groups between 31-40. 
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2. Sex: 
  
S.NO SEX NO OF CASES PERCENTAGE 
1.    Male 18 60% 
2.  Female 12 40% 
Total  30 100% 
 
 
 
 
 
 
Observation:Among the 30 patients selected for this study, 60% were males and 40% were 
females. 
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3.Occupational: 
 
S.NO NATURE OF WORK NO OF CASE PERCENTAGE 
1. Students 4 13.3% 
2. Workers 15 50% 
3. Home maker 7 23.3% 
4. Unemployed 4 13.3% 
Total  30 100% 
 
 
NATURE OF WORK 
 
 
 
 
Observation: Among this study  majority of patients were workers. 
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4.Family history: 
 
S.NO CRITERIA NO OF CASE PERCENTAGE 
1. Family History (Relevant) 03 10% 
2. Family History (No relevant) 27 90% 
Total  30 100% 
 
 
 
Observation:  In this study only 3 number (10%) of cases had positive family history. 
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 5.Dietary habits: 
 
 
S.NO Dietary habits NO OF CASE PERCENTAGE 
1. Vegetarian 3 10% 
2. Non-vegetarian 27 90% 
Total  30 100% 
 
 
 
 
 
 
Observation: In this study only 90% of Patients were Non Vegetarian. 
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 6. Thinai reference: 
 
 
 
 
S.NO THINAI NO OF CASE PERCENTAGE 
1. Kurinji (Hill Area) 0 0% 
2. Mullai (Forest Area) 0 0% 
3. Marutham (Fertile Land) 4 13.3% 
4. Neithal (Coastal Area) 26 86.6% 
5. Paalai (Desert Land) 0 0% 
Total  30 100% 
 
 
 
 
 
Observation:      In this study 86.6% of the patients were from neithal, 13.3%% were from 
marutham. 
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7.KAALAM DISTRIBUTION: 
 
 
S.NO KALAM NO OF CASE PERCENTAGE 
1. Kaar kaalam 0 0% 
2. Koothir kaalam 3 10% 
3.   Munpani kaalam 12 40% 
4.   Pinpani kaalam 14 46.6% 
5. Elavenil kaalam 1 3.3% 
6. Muthuvenil kaalam 0 0% 
Total  30 100% 
 
KAALAM 
 
 
         
 
 
Observation:   Among 30 patients, 46.6% of patients underwent treatment in Pinpani kaalam. 
40%,10%, 6.6% of patients  underwent treatment during munpani kaalam,koothir kaalam and 
Elavenil Kaalam respectively.
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 8. Yaakai Ilakkanam (Physical Constitution): 
 
S.NO YAKKAI 
 
ILAKKANAM 
NO OF CASES PERCENTAGE 
1. Vadha udal 0 0% 
2. Pitha udal 0 0% 
3. Kapha udal 0 0% 
4. Vaatha pitha udal 08 26.7%% 
5. Pitha vaatha Udal 18 60% 
6. Kapha pitha Udal 04 13.3% 
 
 
 
 
 
 
 
  
 
Observation:   All the patients (100%) belongs to Thontha Udal.In specifically 8 of the cases 
belongs to Vaatha pitham, 18 of the cases belongs to Pitha vaatham and $ cases belongs to 
Kapha pitham. 
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  9. Gunam (Quality and Characters): 
 
S.NO GUNAM NO OF CASE PERCENTAGE 
1. Sathuva gunam -  
2. Rajo gunam 30 100% 
3. Thamo gunam -  
 
 
   
 
 
Observation:  All of the patients 30(100 %) possesed “Rajo Gunam” 
0 10 20 30
Gunam
Thamo Gunam
Rajo Gunam
Sathuvam
  
 
 
 
 
 
 
 
 
 
 
 
10. Duration of Illness: 
 
S.NO DURIATION OF 
 
ILLNESS 
NO OF CASE PERCENTAGE 
1. Below one year 9 30% 
 2. Above 1-2 years 8 26.6% 
3. Above 2-3 years 9 30% 
4. Above 3 years 5 16.6% 
 
 
 
 
DURIATION OF ILLNESS 
  
 
 
 
 
Below one year 
Above 1-2 years 
Above 2-3 years 
Above 3 years 
 
 
 
 
 
 
 
Observation:    Among 30 patients 30% of cases were suffering for less than one year and 
another 30% of people were suffered for 2-3 year, 26.6% of cases suffered for 1-2year, 
16.6% were suffered above 3 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
11.Distribution of Mukkutram: 
 
The derangements of Vaatham,Pitham and Kapham in Viyagula Unmaatham as follows, 
 
 VATHAM: 
 
S.NO CLASSIFICATION OF 
 
VATHAM 
NO OF CASE PERCENTAGE 
1. Pranan 30 100% 
2. Abanan 10 33.3% 
3. Udhanan 0 0% 
4. Samanan 0 0% 
5. Viyanan 0 0% 
6. Naagan 30 100% 
7. Koorman 0 0% 
8. Kirukaran 0 0% 
9. Devathathan 0 0% 
10. Dananjeyan 0 0% 
 
 
Observation:  All of  the 30 cases are affected by Praanan,Naagan.The  Abaanan is affected in 
33.3% of cases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
PITHAM: 
  
S.NO CLASSIFICATION OF 
 
PITHAM 
NO OF CASE PERCENTAGE 
1. Anal pitham 0 0% 
2. Ranjagam 0 0% 
3. Sadhagam 30 100% 
4. Prasagam 0 0% 
5. Alosagam 0 0% 
Total  30 100% 
 
 
 
 
 
 
 
Observation:  Among all of the patients are affected by Saathaga pitham. 
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 KAPHAM: 
 
S.NO CLASSIFICATION OF 
KAPHAM 
NO OF CASES PERCENTAGE 
1. Avalambagam 0 0% 
2. Kilethagam 0 0% 
3. Tharpagam 0 0% 
4. Pothagam 0 0% 
5. Santhigam 16 53.3% 
 
 
Observation: Santhigam was  affected  in 53.3% of cases. 
 
12. UDAL KATTUGAL: 
 
S.NO UDAL KATTUGAL NO OF CASE PERCENTAGE 
1. Saram 30 100% 
2. Seneer 0 0% 
3. Oon 0 0% 
4. Kozhupu 0 0 
5. Enbu 0 0 
6. Moolai 0 0 
7. Sukkilam/suronitham 10 33.3% 
 
      
 
Observation:  Among 30 patients, Saaram was affected in all the cases. 
Sukkilam/Suronitham was affected in 10 patients respectively. 
0
5
10
15
20
25
30
35
Udal Thathukkal
Saaram
Senneer
Oon
Kozhuppu
Enbu
Moolai
Sukkilam/Suronitham
 13. EN VAGAI THERVUGAL: 
 
 
S.NO 
    
     EN VAGAI THERVUKAL 
 
   NO OF CASE 
 
PERCENTAGE (%) 
1. NAADI:     BT      AT         BT         AT 
Vatha pitham 08     16 26.6%     53.3% 
Pitha vatham 16     11 53.3%     36.6%  
Pitha Kapham 02      01 6.6%     3.3% 
Kapha pitham 04      02 13.3%     6.6% 
2. Sparisam 0      0% 0%     0% 
3. Naa 0      0% 0%     0% 
4. Niram 0      0% 0%     0% 
5. Mozhi 0      0% 0%     0% 
6. Vizhi 0      0% 0%     0% 
7. Malam 10      02 33.3%     6.6% 
 
8th examination discussed separately. 
 
Observation: 
 Among 30 cases, 53.3% of cases had Pithavaatham naadi and 26.6%,6.6%,13.3% of 
cases had Vaatha pitham naadi,Pitha vaatham naadi,Pitha kapham and Kapha pitham naadi 
respectively while the beginning of study.Among the 30 cases The Malam is affected in 33.3% 
cases. After the study  the among 30 cases 53.3% , 36.7% ,3.3% and 6.6% of cases had Vaatha 
pitham, Pitha vaatham, Pitha kapham and Kapha pitham respectively. 6.6%  of cases had 
affected in the Malam thaathu.  
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 14.NEER KURI & NEI KURI: 
 
 
A. NEERKURI: 
 
S.NO     TYPE OF TEST       NO OF CASE PERCENTAGE 
    BT      AT    BT    AT 
1. Niram (pale yellow) 30   30 100%   100% 
 
B.NEI KURI: 
 
S.NO TYPE OF TEST      NO OF CASE PERCENTAGE 
      BT    AT   BT    AT 
1. Vatham (aravena 
 
neendathu) 
08   14 26.7 46.7% 
2. Pitham (aazhi poi 
 
paraviyathu) 
18   14 60% 46.7% 
3. Kapham (muththothu 
 
nindrathu) 
04   02 13.3% 6.6% 
 
 
Observation: 
  
Before treatment all the 30 cases shown pale yellow colour in Neerkuri 
Examination.Among the 30 cases 18 patient`s  Neikuri related with Pitham.And 
Vaatham and Kapham were related with 08 and 04 cases respectively.After 
treatment all the 30 cases shown pale yellow colour in Neerkuri Examination. 
Each 14 patients  Neikuri related with Pitham and Vaatham . 2 of the cases 
related with Kapham.
 INVESTIGATIONS BEFORE AND AFTER TREATMENT(HEMATOLOGY) 
 
S. 
No 
OP. 
No. 
Age/Sex Hb (gm/dl) Total RBC count 
 
(million/cu.mm) 
ESR 
(mm/hr) 
Total WBC 
(cells/cu.mm) 
BT AT BT AT BT AT BT AT 
1. L7293 36/M 13.0 13.2 4.7 4.8 10/22 10/22 9400 9800 
2. J82877 24/F 11.4 11.2 4.1 4.0 10/20 10/20 9000 9000 
3. K22503 30/M 12.7 12.1 4.9 4.8 10/22 10/22 8400 9000 
4. K6216 44/M 16.1 16.0 6.2 5.9 2/4 2/4 5500 5200 
5. K44289 41/M 13.1 13.3 4.3 4.5 8/16 6/14 6100 7500 
6. L29758 23/F 10.2 10.4 4.0 4.1 16/32 16/32 6500 6300 
7. K42302 35/M 15.5 13.8 5.2 4.8 4/8 10/22 5300 9200 
8. L25184 34/M 13.1 13.2 4.9 4.9 4/10 4/8 8400 10200 
9. L36326 56/F 12.6 11.7 4.1 3.9 14/30 14/30 7200 7600 
10. L39314 45/F 15.1 14.1 5.0 5.2 2/4 4/8 5100 10000 
11. L13060 31/F 12.4 12.0 4.2 4.0 12/26 10/20 4500 4500 
12. L18963 21/M 13.7 13.8 5.1 5.2 4/8 4/8 4600 4800 
13. K33442 33/M 13.6 13.8 5.0 5.1 4/10 4/10 12100 12100 
14. K34254 46/F 14.5 14.1 4.9 4.8 6/14 6/12 7700 7800 
15. L18195 47/M 15.4 15.1 5.3 5.2 2/4 2/4 5500 5200 
16. L33967 47/F 13.9 13.4 5.1 5.9 6/12 6/12 9000 9000 
17. K90459 42/M 12.0 118 4.7 4.7 30/66 30/66 14000 11500 
18. K66988 59/F 13.9 14.5 5.0 5.1 4/12 4/8 8500 10300 
19. J39630 40/M 14.7 14.3 4.9 4.8 4/8 10/22 6100 6300 
20. L35741 30/F 15.2 13.7 5.1 4.5 2/4 4/8 6900 9300 
  
 
21. L33159 30/M 11.0 9.5 4.1 3.6 30/62 30/66 8400 7000 
22. L46576 40/M 13.9 14.2 4.4 4.7 2/4 16/32 10700 8000 
23. L3927 36/M 12.3 12.4 4.6 4.6 10/22 10/22 9100 8900 
24. K03174 40/M 15.0 14.4 5.2 5.0 16/34 16/32 8400 6600 
25. K15768 26/M 13.3 13.9 4.5 4.8 10/22 10/22 9200 5200 
26. K12113 30/F 14.3 14.2 4.8 4.8 4/8 4/8 9400 9000 
27. K07097 33/F 14.4 14.7 5.0 5.2 4/8 4/8 6800 7400 
28. K12855 25/F 12.4 12.8 4.0 4.2 20/42 22/42 8800 9000 
29. K13418 28/M 13.7 15.5 4.5 4.8 30/66 4/8 8600 10200 
30. K01901 35/M 13.7 13.8 4.7 4.2 30/62 30/66 5700 5200 
 INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
 
S.No OP. No Age/ 
Sex 
SGOT SGPT Alkaline phosphatase 
BT AT BT AT BT AT 
1. L7293 36/M 20 16 14 11 72 60 
2. J82877 24/F 15 20 07 17 40 68 
3. K22503 30/M 07 10 10 12 88 93 
4. K6216 44/M 25 28 12 17 59 55 
5. K44289 41/M 12 20 05 25 64 66 
6. L29758 23/F 12 12 06 10 53 64 
7. K42302 35/M 33 30 49 45 50 67 
8. L25184 34/M 26 15 58 21 91 82 
9. L36326 56/F 16 19 17 27 53 51 
10. L39314 45/F 24 23 17 20 50 60 
11. L13060 31/F 22 25 16 16 74 70 
12. L18963 21/M 25 25 33 30 76 80 
13. K33442 33/M 16 30 19 25 57 80 
14. K34254 46/F 18 20 15 18 60 72 
15. L18195 47/M 17 20 15 17 78 82 
16. L33967 47/F 16 13 11 15 98 98 
17. K90459 42/M 18 28 39 24 77 80 
18. K66988 59/F 14 20 18 16 71 75 
19. J39630 40/M 16 17 11 13 60 72 
20. L35741 30/F 14 16 28 28 72 75 
 INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
 
S. No OP. No Age/Sex SGOT SGPT Alkaline 
phosphatase 
BT AT BT AT BT AT 
21. 
L33159 
30/M 15 15 30 11 53 49 
22. 
L46576 
40/M 47 16 59 20 58 70 
23. 
L3927 
36/M 13 15 07 11 104 105 
24. 
K03174 
40/M 17 14 20 22 96 87 
25. 
K15768 
26/M 14 21 08 19 71 73 
26. 
K12113 
30/F 16 20 20 43 68 72 
27. 
K07097 
33/F 14 18 20 34 60 57 
28. 
K12855 
25/F 17 16 09 10 50 62 
29. 
K13418 
28/M 22 32 14 28 74 85 
30. 
K01901 
35/M 14 18 19 24 91 82  
 INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
 
S. No OP. No Age/Sex Total bilirubin Direct bilirubin Indirect bilirubin 
BT AT BT AT BT AT 
1. L7293 36/M 0.5 0.5 0.1 0.2 0.3 0.3 
2. J82877 24/F 0.9 0.8 0.4 0.4 0.5 0.5 
3. K22503 30/M 0.4 0.4 0.2 0.1 0.2 0.3 
4. K6216 44/M 0.3 0.4 0.2 0.2 0.1 0.2 
5. K44289 41/M 0.3 0.4 0.2 0.2 0.1 0.2 
6. L29758 23/F 0.5 0.5 0.2 0.2 0.3 0.3 
7. K42302 35/M 0.5 0.6 0.1 0.1 0.3 0.4 
8. L25184 34/M 0.2 0.3 0.1 0.1 0.1 0.2 
9. L36326 56/F 0.6 0.4 0.2 0.1 0.4 0.3 
10. L39314 45/F 0.9 0.8 0.4 0.4 0.5 0.5 
11. L13060 31/F 0.3 0.4 0.2 0.1 0.1 0.2 
12. L18963 21/M 1.4 1.2 0.6 0.3 0.8 0.6 
13. K33442 33/M 1.7 1.6 0.5 0.4 1.2 0.7 
14. K34254 46/F 2.2 1.2 0.7 0.7 1.5 1.4 
15. L18195 47/M 0.6 0.6 0.3 0.2 0.3 0.2 
16. L33967 47/F 0.7 0.4 0.3 0.1 0.4 0.3 
17. K90459 42/M 0.3 0.4 0.1 0.2 0.2 0.3 
18. K66988 59/F 0.2 0.6 0.1 0.2 0.1 0.1 
19. J39630 40/M 0.5 0.6 0.2 0.1 0.3 0.4 
20. L35741 30/F 0.4 0.5 0.1 0.1 0.3 0.4 
 INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
 
S. No OP. No Age/Sex Total bilirubin Direct bilirubin Indirect bilirubin 
BT AT BT AT BT AT 
  21. 
L33159 
30/M 0.7 1.0 0.3 0.4 0.4 0.6 
22. 
L46576 
40/M 0.9 0.6 0.4 0.2 0.5 0.4 
23. 
L3927 
36/M 0.8 0.8 0.3 0.3 0.5 0.5 
24. 
K03174 
40/M 0.6 0.6 0.2 0.2 0.4 0.4 
25. 
K15768 
26/M 0.7 0.7 0.3 0.3 0.4 0.4 
26. 
K12113 
30/F 1.4 1.2 0.4 0.4 0.9 0.8 
27. 
K07097 
33/F 0.7 0.8 0.3 0.3 0.4 0.5 
28. 
K12855 
25/F 0.6 0.7 0.3 0.3 0.3 0.4 
29. 
K13418 
28/M 0.5 0.6 0.1 0.1 0.4 0.3 
30. 
K01901 
35/M 0.4 0.4 0.6 0.5 0.1 0.2 
  
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT (RENAL FUNCTION TEST) 
 
S. No OP. No Age/Sex Blood sugar 
 
Fasting 
Blood sugar 
 
Post prandial 
Urea Creatinine 
BT AT BT AT BT AT BT AT 
1. L7293 36/M 90 88 124 115 18 15 0.8 1.2 
2. J82877 24/F 94 90 100 115 25 18 0.7 0.8 
3. K22503 30/M 100 95 148 135 35 30 0.8 0.8 
4. K6216 44/M 97 90 96 116 17 20 1.0 1.0 
5. K44289 41/M 93 81 83 93 11 14 0.9 0.8 
6. L29758 23/F 78 88 95 87 17 15 1.0 0.9 
7. K42302 35/M 105 85 120 110 21 24 1.0 0.8 
8. L25184 34/M 88 92 107 191 19 19 0.8 0.8 
9. L36326 56/F 98 104 104 169 14 13 0.7 0.8 
10. L39314 45/F 89 93 97 118 22 25 0.8 1.0 
11. L13060 31/F 94 85 102 110 14 23 0.8 1.0 
12. L18963 21/M 105 93 93 115 13 20 1.0 0.8 
13. K33442 33/M 107 105 129 127 19 19 0.8 0.7 
14. K34254 46/F 92 95 117 123 11 15 0.9 0.7 
15. L18195 47/M 115 105 117 127 12 15 1.1 0.9 
16. L33967 47/F 97 101 124 130 17 15 0.8 0.7 
17. K90459 42/M 97 104 139 124 20 19 0.9 0.6 
18. K66988 59/F 82 98 106 119 19 24 1.0 0.8 
19. J39630 40/M 88 93 109 125 15 23 1.2 0.9 
20. L35741 30/F 95 83 148 140 27 32 0.9 0.7 
  
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT (RENAL FUNCTION TEST) 
 
S. No OP. No Age/Sex blood sugar 
fasting 
Blood sugar 
 
Post prandial 
Urea Creatinine 
BT AT BT AT BT AT BT AT 
21. 
L33159 
30/M 94 107 98 102 15 16 0.8 0.9 
22. 
L46576 
40/M 116 121 129 115 24 13 1.0 1.1 
23. 
L3927 
36/M 95 86 96 114 13 18 0.8 0.9 
24. 
K03174 
40/M 96 125 124 136 18 21 1.3 1.3 
25. 
K15768 
26/M 95 104 137 104 12 12 0.8 0.9 
26. 
K12113 
30/F 101 111 132 127 21 22 1.1 1.1 
27. 
K07097 
33/F 95 105 128 116 19 16 1.2 1.1 
28. 
K12855 
25/F 101 95 121 115 25 20 0.8 0.7 
29. 
K13418 
28/M 83 90 118 123 39 25 1.1 0.8 
30. 
K01901 
35/M 85 124 96 121 18 25 1.3 0.9 
  
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT (URINE ROUTINE TEST) 
 
S. No OP. No Age 
 
/Sex 
Urine 
sugar 
fasting 
Urine sugar 
 
Postprandial 
albumin Deposits 
Epithelial 
cells 
Pus cells 
BT AT BT AT BT AT BT AT BT AT 
1. L7293 36/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
2. J82877 24/F NIL NIL NIL NIL NIL NIL 1-2 1-2 2-4 1-2 
3. K22503 30/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
4. K6216 44/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
5. K44289 41/M NIL NIL NIL NIL NIL NIL 2-4 2-4 1-2 1-2 
6. L29758 23/F NIL NIL NIL NIL NIL NIL 3-5 6-8 3-5 2-4 
7. K42302 35/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
8. L25184 34/M NIL NIL NIL NIL NIL NIL 2-4 1-2 3-5 1-2 
9. L36326 56/F NIL NIL NIL NIL NIL NIL 1-2 2-3 2-3 2-3 
10. L39314 45/F NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
11. L13060 31/F NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
12. L18963 21/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-3 2-4 
13. K33442 33/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
14. K34254 46/F NIL NIL NIL NIL NIL NIL 1-2 1-3 3-5 1-3 
15. L18195 47/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
16. L33967 47/F NIL NIL NIL NIL NIL NIL 1-2 1-3 1-2 1-3 
17. K90459 42/M NIL NIL NIL NIL NIL NIL 2-4 2-4 2-4 2-4 
18. K66988 59/F NIL NIL NIL NIL NIL NIL 2-3 2-4 2-4 1-2 
19. J39630 40/M NIL NIL NIL NIL NIL NIL 1-2 1-3 1-2 1-2 
20. L35741 30/F NIL NIL NIL NIL NIL NIL 1-2 1-2 4-6 3-4 
  
 
 
 
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT (URINE ROUTINE TEST) 
 
S. No OP. No Age/Sex Urine 
sugar 
fasting 
Urine 
sugar 
Post 
prandial 
albumin Deposits 
Epithelial 
cells 
Pus 
cells 
BT AT BT AT BT AT BT AT BT AT 
21. 
L33159 
30/M NIL NIL NIL NIL NIL NIL 3-5 1-2 1-2 1-2 
22. 
L46576 
40/M NIL NIL NIL NIL NIL NIL 1-2 1-2 3-5 3-5 
23. 
L3927 
36/M NIL NIL NIL NIL NIL NIL 1-2 2-4 1-2 2-4 
24. 
K03174 
40/M NIL NIL NIL NIL NIL NIL 2-4 2-4 2-4 2-4 
25. 
K15768 
26/M NIL NIL NIL NIL NIL NIL 1-2 1-3 2-3 4-6 
26. 
K12113 
30/F NIL NIL NIL NIL NIL NIL 1-2 1-2 2-4 1-2 
27. 
K07097 
33/F NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 2-4 
28. 
K12855 
25/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-3 1-2 
29. 
K13418 
28/M NIL NIL NIL NIL NIL NIL 2-4 1-2 2-4 1-2 
30. 
K01901 
35/M NIL NIL NIL NIL NIL NIL 1-4 1-2 3-5 1-4 
 19. RESULTS AND STATISTICAL ANALYSIS: 
 
All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. SPSS software was used to perform statistical analysis. Basic 
descriptive statistics include frequency distributions and cross-tabulations were performed. The 
quantity variables were expressed as Mean ± Standard Deviation and qualitative data as 
percentage. A probability value of <0.05 was considered to indicate as statistical significance. 
Paired ‘t’ test was performed for determining the significance between before and after 
treatment. 
 
21.Observation of Trial Medicine before and after treatment (Based on BECK DEPRESSION  
SCALE) 
 
As per the BECK Depression Inventory Scale the score is calculated before and after treatment  
and categorized into Good, Moderate and Mild Improvement. 
 
             
                      Level 
 
    Grade 
 
Normal 
 
 Grade 0 (1-10) 
 
Mild Mood Disturbance 
  
 Grade 1 (11-16) 
 
Borderline Clinical Depression 
  
 Grade 2 (17-20) 
 
Moderate Level Depression 
 
 Grade 3 (21-30) 
 
Severe Level Depression 
  
 Grade 4 (31-40) 
 
 
  Before Treatment   After Treatment  Improvement 
Grade 3 Grade 0 Good 
Grade 3 Grade 1 Moderate 
Grade 3 Grade 2 Mild 
Grade 2 Grade 0 Moderate 
Grade 2 Grade 1 Mild 
 
 
 
 
 
 
 S.NO OP. NO AGE/ 
 
SEX 
   BT 
(Score) 
     AT 
  (Score) 
RESULTS 
1. L7293 36/M 22 12 MODERATE 
2. J82877 24/F 22 8   GOOD 
3. K22503 30/M 26 6 GOOD 
4. K6216 44/M 20 12 MODERATE 
5. K44289 41/M 22 6 GOOD 
6. L29758 23/F 22 6   GOOD 
7. K42302 35/M 20 10 MODERATE 
8. L25184 34/M 18 4 MODERATE 
9. L36326 56/F 22 6 GOOD 
10. L39314 45/F 22 8 GOOD 
11. L13060 31/F 20 8 MODERATE 
12. L18963 21/M 26 4 GOOD 
13. K33442 33/M 24 6 GOOD 
14. K34254 46/F 27 12 MODERATE 
15. L18195 47/M 24 16 MODERATE 
16. L33967 47/F 20 8 MODERATE 
17. K90459 42/M 24 4 GOOD 
18. K66988 59/F 21 8 GOOD 
19. J39630 40/M 20 4 MODERATE 
20. L35741 30/F 22 16 MODERATE 
21. L33159 30/M 20 8 MODERATE 
22. L46576 40/M 21 7 GOOD 
23. L3927 36/M 24 6 GOOD 
24. K03174 40/M 22 10 GOOD 
25. K15768 26/M 23 11 MODERATE 
26. K12113 30/F 21 8 GOOD 
27. K07097 33/F 19 10 MODERATE 
28. K12855 25/F 20 6 MODERATE 
29. K13418 28/M 24 14 MODERATE 
30. K01901 35/M 26 13 MODERATE 
 
 
 
 
 
  
Paired ,Sample ,Statistics ,(BECK Depression scale Score ,Before ,Treatment ,and ,After 
,Treatment) ,: 
 
Variable Sample ,size 
Before 
,treatment 
After 
,Treatment , 
t ,Value p ,Value 
,Mean±SEM 
 
30 
 
22.13±1.02 8.57±1.53 t ,= ,7.374 p ,<0.0001 
 
 
 
   Figure ,     .Paired ,Sample ,Statistics 
Inference: 
 The ,mean ± ,SEM ,of , BECK Depression scale Score ,at ,before ,and ,after ,treatment were 
22.13±1.02 and 8.57±1.53 respectively ,which ,is ,statistically ,extreamly ,significant ,(t ,= , 7.374, ,p 
,<0.0001). , 
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BECK DEPRESSION SCALE SCORING 
 
S.NO RESULTS NO OF CASES PERCENTAGE 
1. Good improvement 14 46.7% 
2. Moderate improvement 16 53.3% 
3. Mild improvement 00 0% 
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 DISCUSSION 
 
 
The Depression is one of the most important psychological problem more common 
among the population. Majority of them are not seeking the help to proper health care providers 
due to social stigma in related with psychological illness. Large numbers of patients perceive 
even the natural physiological function as abnormal. The Depression is rampant among the 
Indian population and leads to large number of physical and psychological symptoms. Majority 
of these individuals visit self-claimed psychiatrist and traditional faith healers. The contact with 
these health providers not only strengthen their misconception and false beliefs, but also 
compel the patients to pay huge cost of investigations and drugs which are not only non- 
effective but also hazardous. This may lead them as a patient in physically and mentally. In 
general practice, most of focus the physicians they attending their patients may missed the 
underlying psychiatric problems. Hence these kinds of patients get more worsened with their 
problems and become a mentally affected patient. 
 
The trial drugs were prepared in Gunapadam lab of National Institute of Siddha after 
the authentication of the raw drugs by Assistant professor of Medicinal botany NIS, Chennai. 
The trial drug was prepared by Standard Operating Procedure as mentioned in the Protocol. 
 
The Bio chemical analysis was done at the biochemistry lab of NIS and the results were 
documented.The Bio-chemical analysis of VENPOOSANI KIRUTHAM had shown presence 
of chloride,Carbonate,Magnesium,Ammonium,Aluminium,Starch,Lead,Iron,Zinc,Alkaloids.. 
The clinical study was conducted with a well-defined protocol and a proper proforma after the 
approval of Institutional Ethical Committee. For this dissertation study, 30 patients were 
selected and patients were treated in the OP Department of Sirappu Maruthuvam, in 
Ayothidoss Pandithar Hospital - National Institute of Siddha, Tambaram Sanatorium, Chennai 
–600 047. 
 
Based on various criteria, the data were collected and tabulated. The criteria were 
family history, age distribution, occupation, dietary habits and incidence of the disease with 
reference to thinai, seasonal variation, clinical manifestations and assessment of the 
improvement in the prognosis of the disease with the trial drug. 
 
In Siddha System, it is necessary to bring the vitiated humors to equilibrium. Hence 
before the treatment Agasthiyar kuzhambu with Inji charu (Zingiber officinale) was given 
 for Viresanam (Purgation) in the early morning to normalize the vitiated humors. During the 
treatment, the patients were advised to follow pathiyam (Dietary regimen). 
 
Internal Drug           : Venpoosani Kirutham- 16ml two times per day with Sugar 
 
External Drug           : Seeraga Thylam for oil bath 2 times per week 
 
Duration of Drug      : 48 days 
 
30 patients were enrolled for this study, among 30 patients, age group 20 to 30 years 
were in number 10 (33.3%), patients between 31 to 40 were in number 11 (36.7 %), patients 
between 41 to 50 years were in number 7 (23.3 %), patients between 51 to 60 years were in 
number  2 (6.6%). 
Viyakula unmatham commonly appears at young and middle age. In this present study, 
considerable numbers of patients were reported (11 patients) between the age of 31-40 years 
among study sample. 
 
Among the 30 patients, male cases were reported in number 18(60%%) and female 
cases were reported in number 12(40%%). Usually the studies carried out on depression, proves 
that female were affected more than male. But the study revealed that, the occurrence more in 
male than the female due to social stigma and lack of awareness on mental health and cultural 
practice in the society. 
 
The majority of patients in this study were common workers 15 (50 %), homemakers 
 
7(23.3%%), unemployed 4(13.3%) and students 4(13.3%). Inference of this study shows that, 
in current scenario employed people are highly exposed to stress often,  nwhich is one of  the 
root cause of depressive disorders. 
 
The most of patients in this study were Non-vegetarian 27 (90%) remaining 3 (10%) 
patients were vegetarian. Inference of this study, shows that people who are consuming high 
non-vegetarian diet, gets aggressive behaviour which may leads to psychiatric disorders. 
 
In this present study shows, considerable numbers of patients were reported from 
 
neithal (26 patients), marutham (4 patients). 
 
Highest number of patients 14 (46.6%) were studied during Pinpani Kaalam, 12 
patients (40%) underwent treatment during Munpani Kaalam, 3 patients (10%) underwent 
treatment during Koothir kaalam and 2 patients underwent treatment during Ilavenil kaalam. 
 
Most of patients 9(30%) were suffering less than one year. Another 9 cases were 
suffered above 2-3 years duration. Hence, 8 cases were suffered above 1-2 years and 5 cases 
 were suffered above 3 years.  
              Laboratory investigations were done for all the cases before and after treatment. There 
were no variations in hepatic, renal and other parameters. 
 
 
All the patients received only trial medicines (Internally & Externally). This trial 
medicine shown results as 14 patients(46.7%)got good improvement and 
16 patients(53.3%) got moderate improvement. 
 
The outcome of this study was clinically observed by Beck Depression Scale Score, 
which showed encouraging results of good improvement in 14 patients (46.7%), moderate 
improvement in 16 patients (53.3%). 
 
 
In this study, no adverse events were observed during the course of the treatment. After 
the study period, all the patients were advised to attend Out Patient Department of Sirappu 
Maruthuvam at NIS for further follow-up of 2 months. 
 SUMMARY 
 
 
The disease Viyakula unmatham was taken for the clinical study with Venpoosani 
Kirutham as internal medicine and Seeraga Thylam for external application to take oil bath 
twice a week, for the clinical study, 30 cases were selected based on the approved protocol. 
 
The raw drugs were authenticated by the competent authority Medicinal Botany and 
 
Gunapadam dept, Botanical Authentication Certificate no: NISMB3612019 . 
 
This study has been approved by IEC of NIS [Date of IEC Approval& its number: 
NIS/13-IEC/201701.05/22.11.2017]. The study is safely executed on patients and there were 
no adverse drug reactions noted during the study period and further registered Clinical Trail 
Registry of India [REG. NO. CTRI/2018/04/013421]. 
 
The results were observed by Beck Depression Scale score. Among the 30 cases 46.7% 
cases had shown good improvement 53.3% cases had shown moderate improvement. The 
study results have revealed that 90%  of the patients  showed  more than  50%  
improvement. 
 CONCLUSION 
 
 
The present clinical study confirmed the efficacy of the trial drug Venpoosani 
Kirutham (internal medicine) and Seeraga Thylam(external medicine) which is a Siddha poly 
herbal formulation. It was found to be efficacious in Viyakula unmatham patients in reducing 
clinical symptoms like depressive mood, loss of sleep and appetite, weight loss, lack of 
concentration, anhedonia, suicidal thoughts etc. The outcome of Beck Depression Scale score 
shows significant reduction of the condition between before and after treatment. The outcome 
shows there is  46.7% of cases had shown good improvement and the rest 53.3% of cases had 
shown moderate improvement.  
 
The clinical trial conducted in selected patients was satisfactory and the results were 
encouraging. However, a study with large number of patients is required to find out the ideal 
dose response. 
 
The costs of the trial medicines are comparatively low. The trail medicines are cost 
effective. 
 
From  the above results,  the trial  drugs  “Venpoosani kirutham” (Internal Medicine) 
and “Seeraga Thylam” (External Medicine) are found to be efficacious in the treatment of 
Viyakula unmatham. 
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CLINICAL STUDY OF SIDDHA DRUGS VENPOOSANI KIRUTHAM (INTERNAL), SEERAGA 
THYLAM (EXTERNAL)  IN THE TREATMENT  OF VIYAGULA UNMAATHAM (DEPRESSION ) 
. 
 
  Principal Investigator : Dr.K.Prabakar                            
SCREENING & SELECTION PROFORMA 
1. SERIAL NO: …………………………….. 2. OP /IP NO: ……………………                              
3. NAME: ……………………………………      4. AGE/GENDER: …………........  
5. OCCUPATION: ………………………….       6. INCOME: …………………….. 
 
INCLUSION CRITERIA 
 
Age: between 20 years and 60 years Yes/No 
Sex: Both male and female Yes/No 
Depressed mood Yes/No 
Reduced level of interest Yes/No 
Considerable loss or gain of weight Yes/No 
Insomnia or hypersomnia Yes/No 
Psychomotor agitation or retardation Yes/No 
Fatigue Yes/No 
Thoughts of extreme guilt Yes/No 
Diminished ability to think or concentrate Yes/No 
Suicidal thoughts Yes/No 
Diabetes mellitus Yes/No 
Willing to participate in trial and signing consent by fulfilling the conditions of  
proforma                       
Yes/No 
Willing to give blood sample for analysis for laboratory investigations Yes/No 
 
DEPARTMENT OF  SIRAPPU MARUTHUVAM 
  
EXCLUSION CITERIA: 
 
 
Pregnancy and lactation 
 
Yes/No 
Diabetes mellitus Yes/No 
Psychosomatic disorders Yes/No 
Cardiac disease Yes/No 
Any other serious systemic illness Yes/No 
 
 
 
 
TRAIL 
 
YES  NO  
If Yes, OPD  IPD  
  Serial NO:  
 
 
Date:        
Station: 
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                           Signature of the HOD   
 
                            
 
 
 
 
 
 NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF  SIREAPPU MARUTHUVAM 
CLINICAL STUDY OF SIDDHA DRUGS VENPOOSANI KIRUTHAM (INTERNAL), 
SEERAGA THYLAM (EXTERNAL)  IN THE TREATMENT  OF VIYAGULA 
UNMAATHAM (DEPRESSION) 
 
  Principal Investigator : Dr.K.PRABAKAR                           
FORM II-A – HISTORY TAKING PROFORMA 
 
STUDY  NO:   OP / IP NO: 
NAME: AGE / GENDER: 
ADDRESS: CONTACT NO : 
 RELIGION :  H / C / M / O. 
OCCUPATION: INCOME: 
MARITAL STATUS :       1. Married 2. Unmarried 
DATE OF INTIAL ASSESSMENT:  
COMPLAINTS & DURATION:   
  
 
 
                                                                                                                                                                            
PERSONAL HISTORY: 
PERSONAL HABITS YES NO 
IF YES SPECIFY 
DURATION 
AMOUNT/Quantity 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic  Drug Addiction     
  
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 
 
 
FAMILY HISTORY:  
Whether this problem runs in family? 1. Yes            2. No    
If yes, mention the relationship of affected person(s) 1._________________ 
 
2._________________ 
  
DIETARY STYLE: 1. Vegetarian    2. Non-vegetarian 
 
MENSTURAL AND OBSTETRIC HISTORY: 
 
 
 
FORM II B  
GENERAL EXAMINATION: 
1. Body weight [Kg]                 :                      
2. Height [cms]                                    :                        
3. Body Temperature [F]        :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.               :   
                                                                                           Yes            No   
8. Pallor   :   
9. Jaundice   :   
10. Clubbing   : 
11. Cyanosis   : 
12. Pedal Oedema   :           
13. Lymphadenopathy            :                                        
14. Jugular venous pulsation   :   
SYSTEMIC EXAMINATION 
  Cardiovascular system                :  
  Respiratory system                 :  
  Gastro-intestinal system                :  
  Central Nervous system                :  
  Urogenital system                 :  
  Endocrine system                             :  
SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1. Vatha udal                                                                             
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
3. KAALAM: 
1. Kaar kaalam    (Aavani-Purattasi) 
 
 
 
 
 2. Koothir kaalam     (Ippasi-Kaarthigai) 
3. Munpani kaalam      (Maargazhi-Thai) 
4. Pinpani kaalam       (Maasi-Panguni) 
5. Ilavenil kaalam        (Chithirai-Vaigasi) 
6. Muthuvenil kaalam (Aani-Aadi) 
 
 
 
4. GUNAM: 
1. Sathuvam  
2. Rasatham 
3. Thamasam 
 
5. PORIPULANGAL (SENSORY ORGANS):          
                  
  
 
 
 
 
 
 
 
6.KANMENDRIYAM (MOTOR ORGANS) : 
        
 
 
 
 
 
 
 
 
 
7. KOSANGAL (SHEATH):                
 
 
 
 
 
 
  
  8. 
 Before treatment After treatment 
Mei (Skin) Normal  / Affected Normal  / Affected 
Vai (Tongue) Normal  / Affected Normal  / Affected 
Kann (Eye) Normal  / Affected Normal  / Affected 
Mooku (Nose) Normal  / Affected Normal  / Affected 
Sevi (Ear) Normal  / Affected Normal  / Affected 
 Before treatment After treatment 
Kai (Upper limb) Normal  /Affected Normal  /Affected 
Kaal (Lower limb) Normal  /Affected Normal  /Affected 
Vai (Oral cavity)   Normal  /Affected Normal  /Affected 
Eruvai (Anal 
region) 
Normal  /Affected Normal  /Affected 
Karuvai (Uro-
Genital region)  
Normal  /Affected Normal  /Affected 
 Before treatment After treatment 
Annamaya kosam Normal  /Affected Normal  /Affected 
Pranamaya kosam  Normal  /Affected Normal  /Affected 
Manomaya kosam  Normal  /Affected Normal  /Affected 
Vignanamaya kosam  Normal  /Affected Normal  /Affected 
Ananthamaya kosam Normal  /Affected Normal  /Affected 
 SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS) 
 
 Before treatment After treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai Normal  /Affected Normal  /Affected 
Sukkilam / Suronitham Normal  /Affected Normal  /Affected 
 
 
 
 
9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
 
A) VALI 
 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
 
 
 
 
 
 
  
 
 
 
B) AZHAL 
 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
 
 
 
 
 
C) IYYAM 
 
 0th day 8th day 15th day 22nd day 29th day 36th day 43rd day 49th day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
Santhigam         
  
 
 
 
 
 
 
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I. NAADI: [PULSE PERCEPTION] 
 
NAADI 0th  day 8th day 15th day 22ndday 29thday 36th  day 43rdday 49thday 
         
 
 
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
0th  day  
8th day  
15th  day  
22nd  day  
29th  day  
36th  day  
43rd day  
49th day  
 
 
 
 
III. NAA: [TONGUE] 
 
NAA 0thday 8thday 15thday 22ndday 29thday 36thday 43rdday 49thday 
         
 
 IV. NIRAM: [COMPLEXION]   
    1. Vadham         
     2. Pitham 
      3. Kabam  
 
V. MOZHI: [VOICE] 
      1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
 
 
 
VI.VIZHI: [EYES] 
VIZHI 0th  day 8th day 15thday 22ndday 29thday 36th  day 43rdday 49thday 
         
 
VII. MALAM: [BOWEL HABITS / STOOLS] 
 Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
 
VIII. MOOTHIRAM [URINE EXAMINATION]   
NEERKKURI: 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
 
 
NEIKKURI:  
 
 Neikkuri Before treatment After treatment 
 Aravana needathu/ 
Snake like pattern 
 
  
Azhipol paraviyathu 
Annular/Ringedpattern 
 
 
 
parav paraparavoiyadu 
  
Muththothu ninrathu  
Pearlbeadepattern 
  
Other patterns   
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD 
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A CLINICAL STUDY OF SIDDHA DRUG VENPOOSANI KIRUTHAM(INTERNAL) AND 
SEERAGA THYLAM (EXTERNAL) FOR THE TREATMENT OF VIYAGULA UNMAATHAM. 
 
  Principal Investigator : Dr.K.PRABAKAR                            
 
1. SERIAL NO:      2. OP /IP NO:                              
3. NAME:            4. AGE/GENDER: 
 
FORM-III - LABORATORY INVESTIGATIONS 
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TMT 
(WITH 
DATE) 
AFTER TMT 
(WITH DATE) 
 
HB( gm/dl) 
M:12-15 
W:11.5-14 
  
 
T.WBC (cells/cu.mm) 
4000-
11000 
  
DIFFERENTIAL Polymorphs 40-75   
 COUNT (%) Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
 
T.RBC(million cells/cu.mm) 
 
M:4.0-5.5 
 W:3.5-4.5 
 
 
 
 
 
  ESR(mm/hour) ½ hr. M:6-12 
W:7-18 
  
 
 
 1 hr.   
Blood Investigations 
Normal 
Values 
Before 
TMT(WITH 
DATE) 
After TMT 
(WITH DATE) 
Blood glucose 
(mg/dl) 
Fasting    70-110   
PP    80-140   
Random    80-120   
RFT (mg/dl) 
Blood urea    16-50   
 
Serum creatinine 
   0.6-1.2   
LFT (IU) 
Total bilirubin    0.2-1.2   
Direct bilirubin    0.1-1.2   
Indirect bilirubin    0.2-0.7   
SGOT     0-40   
SGPT     0-35   
 Alkaline 
phosphatase 
   80-290   
RA FACTOR     
CRP     
ASO TITRE     
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Date:          
 
Station: 
 
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                              Signature of the HOD 
 
 
Urine investigation Before Treatment(with Date) After Treatment (With Date) 
Neerkuri   
Niram   
Edai   
Manam   
Nurai   
Enjal   
Nei kuri   
Albumin   
Fasting sugar   
PP sugar   
Deposits 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                              
 
                                             
 
 
 
 
 
 
 
 
 
 
 
 
 NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
CLINICAL STUDY OF SIDDHA DRUG VENPOOSANI KIRUTHAM (INTERNAL) AND 
SEERAGA THYLAM (EXTERNAL) FOR THE TREATMENT OF VIYAGULA UNMAATHAM. 
  Principal Investigator : Dr.K.PRABAKAR                            
 
FORM –VI- DRUG COMPLIANCE FORM 
SERIAL NO:                                                                                                      
NAME:  
DRUG NAME:  
On 1st     day-Date: Drugs issued: (gms) Drugs returned:    (gms) 
On 8th   day-Date:  Drugs issued: (gms) Drugs returned:    (gms) 
On 15th day-Date:             Drugs issued: (gms) Drugs returned:    (gms) 
On 22th day-Date:           Drugs issued: (gms) Drugs returned:    (gms) 
On 29th day-Date:             Drugs issued: (gms) Drugs returned:    (gms) 
On 36th day-Date:             Drugs issued: (gms) Drugs returned:    (gms) 
On 43th day-Date:            Drugs issued: (gms) Drugs returned:    (gms) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD 
   Day    Date          Morning   Evening   Day    Date    Morning   Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23    Day47    
Day24    Day 48    
 NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
CLINICAL STUDY OF SIDDHA DRUGS VENPOOSANI  KIRUTHAM(INTERNAL), 
SEERAGA THYLAM (EXTERNAL)  IN THE TREATMENT  OF VIYAGULA 
UNMAATHAM (DEPRESSION ) 
Principal Investigator : Dr.K.PRABAKAR                           
                                 FORM V– PATIENT INFORMATION SHEET 
Name of Principal Investigator: Dr.K.Prabakar 
Guide: Dr.V.Mahalakshmi.MD (s),Ph.D 
Name of the institute:   National Institute of Siddha, 
                                      Tambaram Sanatorium, Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE CLINICAL TRIAL 
       I am Dr.K.Prabakar studying M.D (Siddha) at National Institute of Siddha, Tambaram 
Sanatorium  doing a trial on ‘‘VIYAGULA UNMAATHAM(DEPRESSION). It is a most 
common psychological problem, occurring throughout the world. In this regard, I  need to ask 
you few questions. I will maintain confidentiality of your comments and data obtained. There 
will be no risk of disclosing your identity and no physical, psychological or professional risk  
involved by taking part in this study. Taking part in this study is voluntary. No compensation 
will be paid to you for taking  part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. There 
is no specific benefit for you if you take part in the study. However, taking part in the study  may  
be of  benefit to the community, as it may help us to understand the problem of defaulters and 
potential solutions. 
             If you agree to be a participant in this study, you will be included in the study primarily 
by signing the consent form and then you will be given the internal medicine VENPOOSANI 
KIRUTHAM (Internal medicine),SEERAGA THAILAM (EXTERNAL MEDICINE) for 48 
days . The information  I collect in this study will remain between you and the principal 
investigator (myself). I will ask you few questions through a questionnaire. I will not write your 
name on this form. Your name won’t be mentioned in the lab investigation form instead a code 
will be used. 
 If you want to know more about this study before taking part, you can ask me all the 
questions you want or contact Dr.K.PRABAKAR, PG Scholar cum principal investigator of this 
study,   National Institute of Siddha, Chennai-47. You can also contact the Member-secretary of  
Ethical committee, National Institute Siddha, Chennai 600047.       
Tel.No: 91-44-22380789, for rights and participation in the study.                         
  
¾¸Åø ÀÊÅõ 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, ¦ºý¨É 47 
                               «§Â¡ò¾¢¾¡Š ÀñÊ¾÷ ÁÕòÐÅÁ¨É, ¦ºý¨É.                                                                            
 
வியாகூல உன்மாதம் ந ாய்க்கான º¢ò¾ ÁÕóÐ¸Ç¢ø வவண்பூசணி கிருதம்  (¯û ÁÕóÐ) 
ÁüÚõ சரீகத்ததலம் (¦ÅÇ¢ ÁÕóÐ)  ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ 
¬öÅ¢ü¸¡É ¾¸Åø  ÀÊÅõ 
 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷:   ÁÕòÐÅ÷ க.பிரபாகர் 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷            §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, 
                                              ¾¡õÀÃõ 
º¡Éð§¼¡Ã¢Âõ, ¦ºý¨É 47 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý வியாகூல 
உன்மாதம் §¿¡Â¢ø ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø ®ÎÀðÎû§Çý.               
-Ð ÀÃÅக் ÜÊÂ §¿¡ö «øÄ. -ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç 
§¸ð¸×õ, §¾¨ÅÂ¡É ¬öÅ¸ ÀÃ¢§º¡¾¨ÉìÌ ¾í¸¨Ç ¯ðÀÎò¾×õ ¯û§Çý. 
-Ð ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ ±É 
¯Ú¾¢«Ç¢ì¸¢§Èý. -¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ò ¦¾¡¨¸Ôõ ÅÆí¸ô À¼ 
Á¡ð¼¡Ð. 
-ó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ Àðºò¾¢ø §¾º¢Â 
º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. 
 -ó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ Àðºò¾¢ø ¯ûÁÕó¾¡¸ 
வவண்பூசணி கிருதம்  (¯û ÁÕóÐ) 16 மி.லி 2 §Å¨Ç (¸¡¨Ä,Á¡¨Ä) ¯½×ìÌ முன் ÁüÚõ  
சரீகத்ததலம் (¦ÅÇ¢ ÁÕóÐ)   48 ¿¡ð¸û பயன்படுத்த §ÅñÎõ.  ¦ÅÇ¢§¿¡Â¡Ç÷¸û 7 
¿¡ð¸ÙìÌ ´ÕÓ¨È ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ.  
-ó¾ ¬Ã¡öîº¢Â¢ø §¿¡Â¢ÉÃ¡¸ §º÷ó¾ À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ -ø¨Ä¦ÂÉ¢ø 
±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ ¦¸¡ûÇÄ¡õ. 
       -ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É ÁÕòÐÅ÷ (Àð¼  §ÁüÀÊôÀ¡Ç÷ º¢ÈôÒ ÁÕòÐÅ Ð¨È) 
«Ï¸×õ. ¨¸§Àº¢ ±ñ 9488101203. 
§ÁÖõ -ó¾ ¬Ã¡öîº¢ìÌ IEC º¡ýÚ ¦ÀÈôÀðÎûÇÐ. -ó¾ ÁÕóÐ வவண்பூசணி கிருதம்  
(¯û ÁÕóÐ) ÁüÚõ சரீகத்ததலம் (¦ÅÇ¢ ÁÕóÐ)  º¢ÈôÀ¡¸ «í¸£¸Ã¢ì¸ôÀð¼ º¢ò¾ 
ÁÕòÐÅ áÄ¢ø ÜறôÀðÎûÇÐ. ²ü¸É§Å ¯À§Â¡¸ò¾¢ø ¯ûÇ -Ð §À¡ýÈ ÁÕóÐ -ÐÅ¨Ã 
§¿¡Â¡Ç¢¸Ç¢¼õ ±ó¾ Å¢¾ Àì¸ Å¢¨Ç×¸¨ÇÔõ ²üÀÎò¾Å¢ø¨Ä. §ÁÖõ ¯½× Ó¨ÈÂ¢ø 
ÁÕòÐÅÃ¡ø ÜÈôÀÎõ Àò¾¢Âõ ¸¡ìÌÁ¡Ú «È¢×Úò¾ôÀÎ¸¢ÈÐ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
CLINICAL STUDY OF SIDDHA DRUGS  VENPOOSANI  KIRUTHAM(INTERNAL), SEERAGA 
THYLAM (EXTERNAL)  IN THE TREATMENT  OF VIYAGULA UNMAATHAM (DEPRESSION )  
 
Principal Investigator : Dr.K.PRABAKAR                            
 
FORM-V  – CONSENT FORM 
 
 
“I have read the foregoing information, or it has been read to me. I have had the opportunity 
to ask questions about it and any questions I have asked have been answered to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand that I have the   
right to withdraw from the study at any time without in any way it affecting my further medical care”. 
 
"I have received a copy of the information sheet/consent form". 
 
Date:  
Signature of the participant 
In case of illiterate participant 
 
        “I have witnessed the accurate reading of the consent form to the potential participant, and the 
individual has had the opportunity to ask questions. I confirm individual has given consent freely.”                                                   
 
Date: 
 
 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)     
     
          
            
 
 
 
 
 
Left thumb Impression of the Participant 
 
 
 
 
  FORM -VI   ´ôÒ¾ø ÀÊÅõ 
                           ¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
¿¡ý  வியாகூல உன்மாதம் ( ÁÉ «Øò¾õ) ±ýÛõ §¿¡Â¢ý ¬ö¨Åì ÌÈ¢ò¾ «¨ÉòÐ 
Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌô ÒÃ¢Ôõ Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 
§¾¾¢:                                        ¨¸¦Â¡ôÀõ: 
                     
þ¼õ:                 ¦ÀÂ÷:                                                
                                         
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
 
±ýÉ¢¼õ  þó¾  ÁÕòÐÅ  ¬öÅ¢ý  ¸¡Ã½ò¨¾Ôõ,  ÁÕó¾¢ý ¾ý¨Á  ÁüÚõ 
ÁÕòÐÅ  ÅÆ¢Ó¨È  ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ  ±ÉÐ  ¯¼ø  þÂì¸ò¨¾ì  ¸ñ¸¡½¢ì¸×õ, 
«¾¨Éô  À¡Ð¸¡ì¸×õ  ÀÂýÀÎõ  ÁÕòÐÅ  ¬ö×ìÜ¼  ÀÃ¢§º¡¾¨É¸û  ÀüÈ¢  
¾¢Õô¾¢ «Ç¢ìÌõ  Å¨¸Â¢ø  ¬ö×  ÁÕòÐÅÃ¡ø  Å¢Çì¸¢ì  ÜÈôÀð¼Ð. 
¿¡ý þó¾ ÁÕòÐÅ  ¬öÅ¢ý  §À¡Ð, ±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ  þó¾  
¬öÅ¢Ä¢ÕóÐ  ±ý¨É Å¢ÎÅ¢òÐ  ¦¸¡ûÙõ  ¯Ã¢¨Á¨Âò ¦¾Ã¢ó¾¢Õì¸¢ý§Èý. 
     ¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ò §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ   வியாகூல 
உன்மாதம் ( ÁÉ «Øò¾õ) §¿¡öì¸¡É வவண்பூசணி கிருதம் (¯û ÁÕóÐ) ÁüÚõ 
சீரகத்ததலம் (¦ÅÇ¢ ÁÕóÐ) ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò  ¾¢È¨Éì  ¸ñ¼È¢Ôõ  ÁÕòÐÅ  
¬öÅ¢üÌ  ±ý¨É  ¯ðÀÎò¾ ´ôÒ¾ø  «Ç¢ì¸¢§Èý. 
 
 
§¾¾¢:                                   ¨¸¦Â¡ôÀõ: 
 
þ¼õ:                         ¦ÀÂ÷:         
 
   
                                          º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
¯È×Ó¨È:  
                                                  ¦ÀÂ÷:                         
            
  
Å¢Ã¢×¨ÃÂ¡Ç¡÷ ¨¸¦Â¡ôÀõ       Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ:  
 NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
. 
CLINICAL STUDY OF SIDDHA DRUGS VENPOOSANI KIRUTHAM (INTERNAL) AND 
SEERAGA THYLAM (EXTERNAL) FOR THE TREATMENT OF VIYAGULA UNMAATHAM 
(DEPRESSION). 
 
  Principal Investigator : Dr.K.PRABAKAR                            
 
FORM VII -A- WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE: …………………   
2. OP / IP NO: ......................................    
3. NAME: ………………………     
4.AGE: …………        
5.GENDER:...........                           
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                              Yes/No 
(If YES, give the details of adverse reaction in Form VII -B – Adverse Reaction 
Form / Pharmaco Vigilance Form) 
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                          Signature of the HOD 
  
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
CLINICAL STUDY OF SIDDHA DRUGS VENPOOSANI KIRUTHAM (INTERNAL) AND 
SEERAGA THYLAM (EXTERNAL) FOR THE TREATMENT OF VIYAGULA 
UNMAATHAM(DEPRESSION). 
 
  Principal Investigator : Dr.K.PRABAKAR                            
 
FORM VII -B – ADVERSE REACTION FORM / PHARMACO VIGILANCE FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
 NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACVTION OCCURS: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
 
 
 
 
 
 
 
Date:                                                                              
Station:  
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                            Signature of the HOD 
 
  
 
                            NATIONAL INSTITUTE OF SIDDHA 
                               AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
CLINICAL STUDY OF SIDDHA DRUGS  VENPOOSANI KIRUTHAM (INTERNAL) AND 
SEERAGA THYLAM (EXTERNAL) FOR THE TREATMENT OF VIYAGULA UNMAATHAM 
(DEPRESSION). 
 
  Principal Investigator : Dr.K.PRABAKAR                           
§º÷ì¸ ÜÊÂ ¯½×¸û: 
¸¡ö¸û: 
ÓÕí¨¸À¢ïÍ, 
«Å¨ÃÀ¢ïÍ, 
À¢Ãñ¨¼, 
¸¡Ãð, 
À£ðåð. 
¸£¨Ã¸û: 
¸Ã¢º¡¨Ä, 
¦À¡ýÉ¡í¸ñ½¢, 
Á½ò¾ì¸¡Ç¢,              
ÓÕí¨¸¸£¨Ã, 
Àº¨Ä¸£¨Ã, 
º¢Ú¸£¨Ã,                 
¸È¢§ÅôÀ¢¨Ä,  
            ¦¸¡ò¾ÁøÄ¢. 
Ò¾¢É¡. 
ÀÆí¸û: 
Á¡Ð¨Ç, 
¬ôÀ¢û, 
Å¡¨Æ, 
§ÀÃ£î¨º, 
«ò¾¢,               
¾¢Ã¡ð¨º, 
¦¸¡öÂ¡                
 ¿¡Åø,  
ºô§À¡ð¼¡, 
¯Ä÷ ¾¢Ã¡ð¨º. 
¾¡É¢Âí¸û  
Ó¨Ç ¸ðÊÂ ÀÂ¢÷ Å¨¸¸û,  
§º¡Â¡À£ýŠ, 
 ¦Åó¾Âõ. 
 
 
«¨ºÅõ: 
¦ÅûÇ¡ðÎ ¸È¢ , 
®Ãø, 
±ÖõÒÁˆ¨ƒ, 
 
ÁüÈ¨Å: 
À¨É ¦ÅøÄõ 
À¡ø   
 
¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û:       
§¸¡Æ¢ì¸È¢, ¸ÕÅ¡Î, 
ÒÇ¢ôÒ ¦À¡Õû¸û, 
¾ì¸¡Ç¢, 
ÒÇ¢ôÒ ¾Â¢÷ §Á¡÷, 
°Ú¸¡ö, 
¦Àñ§À¡¸õ, Ò¨¸Â¢¨Ä , 
¦ÅüÈ¢¨Ä,À¡ìÌ. 
 
 
 
 
 
 
 
 
